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CHAPTER 1 
INTRODUCTION 
 Fibromyalgia (FM) impacts millions of individuals around the world and is 
characterized by widespread chronic pain and tenderness as well as nonrestorative 
sleep, fatigue, and stiffness (Wolfe et al., 1990; Wolfe et al., 2010).  It is a costly 
condition, both in terms of financial burden as well as disability and reduced quality of 
life (Berger et al., 2010; Mease, 2005). In addition, more than 90% of individuals with 
FM report poor sleep quality, and this is often described as light and unrefreshing sleep 
(Moldofsky, 2008). The high prevalence of sleep disturbance in FM suggests that this 
may be a contributing factor to the pain experience.  
The relationship of sleep and pain is well established in the literature; however, 
the direction of this relationship is unclear. Experimental studies have been conducted 
with healthy, pain-free people in order to test the directionality of the sleep and pain 
relationship. Studies involving sleep restriction and total sleep deprivation have found 
increased pain sensitivity the next day compared with no restriction conditions (Haack & 
Mullington, 2005; Onen, Alloui, Gross, Eschallier, & Dubray, 2001; Roehrs, Hyde, 
Blaisdell, Greenwald, & Roth, 2006). Research has also found that disrupted sleep 
continuity, rather than restricted sleep, is a significant predictor of next day’s pain 
(Smith, Edwards, McCann, & Haythornthwaite, 2007). These experimental findings on 
individuals without chronic pain conditions suggest that disturbed sleep may amplify the 
pain found in individuals with chronic pain. 
Studies have also been conducted on chronic pain populations including 
rheumatoid arthritis and FM, focusing on how poor sleep results in increased pain. 
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Ağargün et al. (1999) found that an increase in subjective sleep problems was 
associated with increased pain sensitivity. A similar study by Kolar et al. (1989) 
assessed problems with sleeping as well as severity of muscle aching, and found that 
sleeping difficulties were associated with tenderness and muscular aching that are 
characteristic of FM. Longitudinal studies have also found that poor sleep at baseline is 
predictive of increased pain after a year (Bigatti, Hernandez, Cronan, & Rand, 2008). 
Research has also focused on the impact of pain on subsequent sleep. Nicassio 
and Wallston (1992) found that arthritis pain predicted sleep disturbance after 2 years, 
but prior sleep disturbance did not predict future pain. Another study by Pilowsky, 
Crettenden, and Townley (1985) found that chronic pain patients who slept poorly 
reported that they slept fewer hours and also reported significantly higher pain intensity 
compared with those who slept normally.  
The prevalence of sleep difficulties in individuals with chronic pain, and especially 
FM, is very high. The relationship between sleep and pain is evident based on the 
literature, although the direction of this relationship remains unclear. Further research is 
needed to determine whether there is a stronger relationship between sleep difficulties 
and subsequent pain or between pain and subsequent sleep problems, in people with 
FM. Research is also needed to explore the factors that predict individual differences in 
this sleep and pain relationship.  
Goals of this Study 
 There were two primary goals for this study. The first was to determine the 
direction of the sleep and pain relationship in a large sample of individuals diagnosed 
with FM. Both objective (actigraphy) and subjective (daily diary) measures of nightly 
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sleep were analyzed to determine the relationship on next day’s pain, as well as 
assessing the relationship between one day’s pain on the next night’s objective and 
subjective sleep variables. The second goal was to assess factors that may account for 
individual differences found in the sleep and pain relationship. Participants completed 
self-report measures of depression, negative affect, pain catastrophizing, and age at 
baseline, and these were analyzed as potential moderators of the relationship between 
sleep and pain. 
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CHAPTER 2 
LITERATURE REVIEW 
Fibromyalgia (FM) is a multifaceted disorder characterized by widespread 
chronic pain and tenderness (Wolfe et al., 1990). Since this initial definition of FM was 
offered in 1990, the criteria for FM have evolved to include nonrestorative sleep, fatigue, 
and stiffness (Wolfe et al., 2010). Fibromyalgia impacts millions of individuals worldwide 
and has an estimated prevalence of 2% of adults in the United States (Arnold, 2010), 
with an approximately 8:1 female to male ratio (Berger, Dukes, Martin, Edelsberg, & 
Oster, 2007; Wolfe, Ross, Anderson, Russell, & Hebert, 1995). The average age of FM 
onset is between 30 and 50 years, and the incidence of FM increases with age, rising in 
middle age (50-59 years) and dropping in older age groups (80 years and above; Wolfe 
et al., 1995). 
Fibromyalgia is a costly condition and one of the 100 most common diagnoses 
made in family medicine (Arnold, 2010). This debilitating syndrome occurs in 5% to 6% 
of adult patients who present at general medical and family practice clinics, and 
between 10% and 20% of patients presenting at rheumatology practices (Goldenberg, 
Simms, Geiger, & Komaroff, 1990; Wolfe et al., 1995). Two studies of large claims 
databases in the United States reported that healthcare costs for people with FM are 2 
to 3 times greater than for individuals without FM due to more frequent doctor’s office or 
emergency room visits and a greater number of prescription medications (Berger et al., 
2010; White et al., 2008). In addition to the financial burden of FM, many patients also 
suffer from disability and reduced quality of life. In a recent review, Mease (2005) 
indicated that there is a greater negative impact on quality of life with FM than many 
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other diseases, including chronic obstructive pulmonary disease and arthritis. Jones, 
Rutledge, Jones, Matallana, and Rooks (2008) conducted a large survey of women with 
FM about how this condition has impacted their activities of daily living. They reported 
that 25% of the women surveyed had difficulty bathing and taking care of personal 
needs, and more than 60% had a difficult time with light housework, lifting or carrying 10 
pounds, traveling up or down one flight of stairs, or walking one half mile (Jones et al., 
2008). 
In addition to chronic widespread pain and tenderness to touch, individuals with 
FM often have a variety of other symptoms and comorbid conditions. Berger and 
colleagues (2007) noted in their recent study from a United States health insurance 
database that, compared with age and sex-matched patients without FM, those with FM 
were more likely to have comorbidities including circulatory disorders, painful 
neuropathies, diabetes, gastroesophageal reflux disorder, irritable bowel disorder, 
anxiety, depression, and sleep disorders. 
Poor sleep quality is reported by more than 90% of individuals with FM, and this 
is often characterized as light and unrefreshing sleep (Moldofsky, 2008). In addition to 
difficulties falling and staying asleep, a complaint of nonrestorative sleep is common. A 
recent review of the literature (Moldofsky, 2009) explored the polysomnographic 
(laboratory sleep study) findings of this population and noted the common disturbances 
in sleep physiology including delayed sleep onset; reductions in sleep efficiency, slow 
wave sleep, and REM sleep; and an increase in motor activity. The high prevalence of 
sleep disturbance in FM suggests that this may be a contributing factor to the pain 
experience.  
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Sleep and Pain 
 Both pain problems and sleep disorders are considered among the most 
common societal complaints, so it is not surprising that these two conditions often co-
occur. What is unclear is the direction of the pain and sleep relationship. A literature 
review by Moldofsky (2001) indicated that millions of Americans complain that their 
experience of nighttime pain interferes with falling asleep, staying asleep, and often 
results in early morning awakenings. Contrariwise, disturbances in sleep have also 
been found to increase the perception of pain. A micro-longitudinal study by Edwards, 
Almeida, Klick, Haythornthwaite, and Smith (2008) found that self-reported sleep one 
night was a significant predictor of the next day’s pain, as well as pain frequency 
predicting sleep duration the following night. Human studies have also found that 
unrefreshing nocturnal sleep in combination with disturbances to sleep physiology result 
in increased daytime musculoskeletal pain and fatigue (Moldofsky, 2001). A more 
recent literature review by Finan, Goodin, and Smith (2013) suggested that impairments 
in sleep may be a more reliable and stronger predictor of pain than pain is of sleep 
impairments. I now review this literature on the relation of sleep disturbances and pain. 
 Experimental Sleep Manipulation and Pain 
To test the directionality of the sleep and pain relationship, experimental studies 
have been conducted with healthy, pain-free people. A study by Onen et al. (2001) 
sought to determine what effect total sleep deprivation, interruptions in slow wave sleep 
and rapid eye movement (REM) sleep, and recovery sleep would have on pain 
threshold as assessed with a pressure dolorimeter. They found that total sleep 
deprivation reduced pain threshold 8% (i.e., increased pain sensitivity) the following 
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day. Although neither slow wave sleep nor REM sleep interruptions resulted in a 
significantly decreased pain threshold, recovery sleep following the slow wave sleep 
interruption led to a 15% increase in pain thresholds. Haack and Mullington (2005) 
discovered that two nights of partial sleep restriction (4 hours) resulted in reports of 
spontaneous bodily pain, and that pain was amplified with subsequent nights of partial 
sleep restriction. Another study by Roehrs et al. (2006) found that both total sleep 
deprivation and sleep restriction significantly reduced pain threshold compared with a 
no sleep reduction condition. These findings provide support for the strong impact that 
sleep restriction has on the next day’s pain. 
 Research has also examined the role of disrupted sleep continuity and 
subsequent pain. Taylor and colleagues (2007) examined the comorbidity of medical 
problems and insomnia and discovered that the most common sleep complaint of 
individuals with chronic pain is multiple awakenings throughout the night as a result of 
pain-related arousals. Smith et al. (2007) developed a sleep disruption paradigm that 
awakens participants pseudorandomly each hour during an 8-hour sleep period in order 
to mimic the continuity disturbance reported by individuals with chronic pain. They 
discovered that healthy female participants who had disrupted sleep continuity reported 
spontaneous pain the following day compared with participants who had an equivalent 
amount of restricted sleep and healthy controls who had uninterrupted sleep for 8 hours. 
These findings suggest that the disruption of continuous sleep may be an even stronger 
predictor of subsequent pain than restriction of sleep. 
 Other research has examined pain sensitivity of sleepy but healthy individuals. 
One study by Chhangani and colleagues (2009) compared the pain sensitivity of sleepy 
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versus alert healthy individuals. The sleepy participants had a reduced pain threshold 
compared with the alert participants. Another study by Roehrs, Harris, Randall, and 
Roth (2012) increased the amount of sleep allowed over 4 nights in sleepy but pain-free 
individuals. This increased time in bed resulted in decreased pain sensitivity compared 
with controls who maintained their regular sleep schedule. These studies provide 
support for the pathway that alterations in sleep influence pain perception.  
Even participants without chronic pain conditions experience a significant 
decrease in pain threshold when sleep is reduced, disrupted, or eliminated. Therefore, 
these experimental findings on people without chronic pain conditions suggest that 
disturbed sleep quality and duration in individuals with chronic pain, such as rheumatoid 
arthritis (RA) and FM, may contribute to their increased pain. 
 Sleep and Pain in Chronic Pain Conditions 
Studies have examined how poor sleep predicts increased pain among people 
with RA. A recent study by Irwin and colleagues (2012) restricted the sleep (4 hours) of 
both healthy participants and individuals with RA. They found that one night of partial 
sleep deprivation resulted in increased self-reported fatigue, anxiety, depression, and 
pain for the participants with RA, but not for the healthy controls. Moldofsky, Lue, and 
Smythe (1983) studied the impact that disturbed sleep has on the morning symptoms 
experienced by people with RA. The patients were found to have an alpha 
electroencephalographic (EEG) sleep anomaly and subsequent arousal state during 
sleep as well as an increase in peripheral joint tenderness the following morning. A 
similar study compared two groups of patients with RA: those who complained of 
morning symptoms and those who were free of such symptoms (Moldofsky, Lue, & 
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Saskin, 1987). Those patients with morning symptoms had fragmented sleep 
characterized by periodic leg movements and repetitive electroencephalographic (EEG) 
arousals compared with those patients without morning symptoms. These studies 
suggest that a nonrestorative sleep disorder may lead to bodily symptoms upon 
awakening. 
 Several studies have also been conducted with FM, focusing on how poor sleep 
results in increased pain. Ağargün et al. (1999) examined the association between pain 
threshold, measured with a manual algometer, and subjective sleep quality. They found 
that an increase in sleep problems was associated with a decreased pain threshold, 
suggesting that greater sleep disturbance is associated with increased pain sensitivity in 
FM. 
Theadom, Cropley, and Humphrey (2007) explored the effect of sleep and coping 
on pain in FM. Participants were asked to complete self-report measures on sleep 
quality, forms of coping, and pain. They found that 99% of participants reported poor 
sleep quality and that this was significantly related to pain, whereas coping strategies 
were not related to pain.  
Bigatti et al. (2008) conducted a longitudinal study that assessed whether 
baseline sleep predicted subsequent pain in participants with FM. They had participants 
complete self-report questionnaires on sleep quality and pain at both baseline and at a 
1-year follow-up assessment. The results suggest that poor sleep is predictive of 
subsequent pain in the FM population, even after a year. 
 Another study that looked at the sleep and pain relationship had participants with 
chronic, widespread, unexplained muscular aching—which is characteristic of FM—
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assess the severity of their muscle aching as well as any problems with sleeping 
including falling asleep, frequent nocturnal awakenings, or waking too early (Kolar et al., 
1989). The results of this study indicate that sleeping difficulties are associated with the 
tender points and muscular aching that are characteristic of FM. Similarly, Davies et al. 
(2008) followed individuals with chronic widespread pain over a period of 15 months 
and found that those participants who reported good quality sleep at the end of the 
study had a resolution of their pain symptoms. These results suggest that restorative 
sleep may improve the long-term prognosis of individuals with chronic pain. 
 Finally, Tang, Goodchild, Sanborn, Howard, and Salkovskis (2012) examined the 
temporal link between sleep and pain in individuals with various chronic pain conditions 
and concomitant insomnia. Participants wore an Actiwatch, a small, watch-like device 
that measures movement and activity level with an embedded accelerometer, and 
completed electronic daily diaries with questions about sleep, pain, mood, and arousal, 
for 7 days. They found that sleep quality was a predictor of pain the next morning, but 
that the effect of high quality sleep did not extend into the following afternoon. Results 
also indicate that pre-sleep pain was not a reliable predictor of the subsequent night’s 
sleep. Rather, sleep was significantly predicted by pre-sleep cognitive arousal.  
These studies of the effects of experimentally manipulated sleep on pain as well 
as the studies conducted with chronic pain populations support the hypothesis that poor 
sleep increases pain. Yet there are another set of studies that have examined the 
impact of pain on subsequent sleep.  
To examine whether the presence of pain predicts subsequent poor sleep, 
Pilowsky et al. (1985) compared the amount of pain experienced between chronic pain 
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patients who slept poorly with those who slept comparatively well. The poor sleepers 
indicated that they slept fewer hours and reported significantly higher pain intensity 
compared with those patients who stated that they slept normally. Another study looked 
at how pain predicts poor sleep in a RA sample. Nicassio and Wallston (1992) collected 
self-report data on sleep disturbance and pain at two different time points within a 2-
year period. Longitudinal regression analyses indicated that arthritis pain predicted 
sleep disturbance after 2 years, but prior sleep disturbance was not found to have an 
impact on subsequent pain. These studies provide support for the impact of pain on 
subsequent sleep. A final category of studies, which I will now review, have found a 
bidirectional relationship between pain and sleep. 
Bidirectional Relationship between Pain and Sleep 
The first study examining the bidirectional relationship between pain and sleep 
was conducted by Affleck, Urrows, Tennen, Higgins, and Abeles (1996) who were 
interested in determining the effect of attention to pain on nightly sleep. Women with a 
diagnosis of FM used palm-top computers to answer daily self-report questions about 
sleep, pain, and attention to pain. They discovered that reports of greater pain during 
the day predicted a worse night’s sleep, and that increased attention to pain also 
predicted poorer sleep. In addition, those individuals who reported sleeping poorly also 
reported more pain and more attention to pain the following day. This study suggests 
that the direction of the sleep-pain relationship may not be conclusive and suggests that 
more research is needed, particularly within FM. 
Another study, which has many design features that parallel the current study, 
evaluated the influence of depression on the bidirectional relationship between sleep 
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and pain in chronic pain patients (O’Brien et al., 2011). Twenty-two women with various 
forms of chronic pain including facial pain, back pain, and fibromyalgia, completed self-
report measures of sleep and pain at baseline as well as daily assessments of sleep 
and pain. Participants wore an Actiwatch for 2 weeks and also completed 2 weeks’ 
worth of sleep diaries and pain ratings. Hierarchical linear modeling analyses indicated 
that there was a bidirectional relationship between subjectively-reported sleep and pain, 
in that a day of increased pain was followed by a night of disrupted sleep, and a night of 
disrupted sleep was followed by increased pain the next day. Analyses on objective 
measures of sleep collected with actigraphy found no significant relationships among 
the sleep and pain variables. O’Brien and colleagues (2011) suggested that the 
subjective experience of sleep has a stronger relationship with reports of pain compared 
with more objective sleep measures.  
There is a high prevalence of sleep difficulties in people with chronic pain, and 
especially FM. Although these studies differ on the directionality of the sleep and pain 
relationship, it is evident that there is a relationship between these two factors. Further 
research is needed to determine whether there is a stronger relationship between pain 
and subsequent sleep difficulties, or between sleep problems and subsequent pain, in 
people with FM. In addition, research is needed to explore the factors that predict 
individual differences in this sleep and pain relationship.  
Moderators of the Sleep and Pain Relationship in Fibromyalgia 
 There are several factors that may aid in predicting the direction and the strength 
of the relationship between sleep and pain in FM. Unfortunately, there is almost no 
literature to guide the study of predictors, but I proposed to examine age, depression, 
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and pain catastrophizing. Theory and an occasional study suggest that these factors 
may predict the direction and strength of the sleep-pain relationship in FM. 
A recent longitudinal study by Mork and Nilsen (2012) evaluated the relationship 
between self-reported sleep difficulties and risk of developing FM. Adult women who did 
not have a diagnosis of FM or any other chronic pain condition were included in the 
study and asked to indicate frequency of sleep problems. These same women were 
assessed approximately 10 years later for the presence of FM. The results indicate that 
the women who developed FM during the follow-up period reported a greater incidence 
of sleep difficulty at baseline compared with those who did not develop FM. When the 
women were stratified into older (≥45 years) and younger (20-44 years) age groups, the 
relative risk of FM development was greater for those women in the older group who 
reported sleep problems, compared with the women in the younger group (Mork & 
Nilsen, 2012). This study speaks to both direction and strength of the sleep-pain 
relationship. It suggests that sleep disturbance may result in FM-related pain, and older 
individuals with sleep difficulties may be at greater risk of developing FM than younger 
individuals. Additional studies provide evidence for significant sleep disruptions in older 
individuals with chronic pain (Lunde, Pallesen, Krangnes, & Nordhus, 2010) as well as 
associations of daily sleep and pain in older individuals with insomnia (Dzierzewski et 
al., 2010). These findings suggest that age is an important potential moderator in the 
sleep-pain relationship.  
 One of the prevalent comorbidities found with FM is depression, which may 
impact sleep fragmentation and sleep loss (Berger et al., 2007; Roehrs & Roth, 2005). A 
recent study by Miró, Martínez, Sánchez, Prados, and Medina (2011) evaluated the role 
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of sleep problems as a mediator of pain intensity on depression. Women with a FM 
diagnosis completed several self-report measures including pain, sleep, and 
depression. Compared with control participants, those with FM had significantly poorer 
sleep and greater levels of depression. Poor sleep quality was significantly correlated 
with greater pain intensity and depression, and pain intensity was also significantly 
correlated with depression levels (Miró et al., 2011). The study described earlier by 
O’Brien and colleagues (2011) evaluated the influence of depression on the relationship 
between sleep and pain in patients with chronic pain. In addition to finding a 
bidirectional relationship between sleep and pain, depressive symptoms also moderated 
this relationship, with participants who reported higher baseline depression levels 
having a stronger sleep-pain relationship than those with lower baseline levels of 
depression. Both of these studies speak to the strength of the sleep and pain 
relationship, suggesting that individuals with higher levels of self-reported depression 
symptoms have a stronger relationship between sleep and pain than individuals with 
lower levels of depression.  
 Pain catastrophizing impacts how individuals experience pain. Campbell, 
Edwards, and Quartana (2009) define pain catastrophizing “as a set of exaggerated and 
negative cognitive and emotional schema brought to bear during actual or anticipated 
painful stimulation.” People who catastrophize tend to do three things: they ruminate 
about their pain, they magnify the severity of their pain, and they feel helpless to 
manage their pain (Sullivan, Bishop, & Pivik, 1995). As a result, individuals who 
catastrophize often attempt to avoid or escape painful experiences (Gatchel, Peng, 
Peters, Fuchs, & Turk, 2007). Pain catastrophizing has been associated with pain 
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sensitivity in experimental pain testing both with healthy individuals and those with 
chronic pain conditions (Edwards, Bingham, Bathon, & Haythornthwaite, 2006; Sullivan 
et al., 2001). A study by Severeijns, Vlaeyen, van den Hout, and Weber (2001) 
examined the relationship between pain catastrophizing and pain intensity and 
psychological distress in individuals with chronic pain. This study did not examine the 
sleep and pain relationship; instead, this study assessed chronic pain patients, who are 
known to have disturbed sleep, and discovered that those individuals who 
catastrophized experienced greater pain intensity and more psychological distress 
including depression. This suggests that individuals with chronic pain, who most likely 
have disturbed sleep as well, will experience greater pain intensity with catastrophizing 
compared with those who do not catastrophize about their pain. 
Aims of this Study 
 The review of the literature provides evidence that sleep and pain are related. 
Experimental sleep manipulation studies resulted in alterations of pain perception, and 
chronic pain populations indicated that poor sleep often resulted in increased pain as 
well as the presence of pain resulting in disrupted sleep. The purpose of this study was 
to determine the direction of the sleep-pain relationship in a FM population as well as to 
uncover any potential factors that might predict individual differences in the sleep-pain 
relationship.  
 The prior literature with chronic pain populations relied almost exclusively on self-
reports of sleep to evaluate the relationship between sleep and pain. Very few studies 
have evaluated daily sleep with an objective measure of actigraphy (O’Brien et al., 
2011; Tang et al., 2012), and these have included only heterogeneous pain populations. 
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The goal of this study was to evaluate the relationship between sleep and pain using a 
large sample of individuals with FM. Sleep was objectively measured with 2 weeks of 
actigraphy along with subjective daily sleep diaries and pain ratings. Baseline self-report 
measures of depression, pain catastrophizing, negative affect and age were also 
evaluated to determine if any of these factors might explain individual differences in the 
sleep / pain relationship.   
 Aim 1. To determine the direction of the sleep-pain relationship for a sample of 
patients with FM. The current literature is unclear regarding direction of the relationship 
between sleep and pain. This study utilized both objective (actigraphy) and subjective 
(daily diary) measures to analyze this relationship. Separate analyses evaluated how 
one night’s subjective and objective sleep variables influenced the next day’s self-
reported pain, as well as how one day’s reported pain influenced the following night’s 
subjective and objective sleep variables. Baseline predictor variables (depression, 
negative affect, pain, sleep quality, pain catastrophizing, and age) were also analyzed to 
determine their effect on the objective and subjective sleep variables as well as self-
reported daily pain. 
 Aim 2. To determine what factors predict individual differences in the relationship 
between sleep and pain. Age, depression, negative affect, and pain catastrophizing 
were each evaluated as potential moderators of this relationship. Based upon the 
literature review, it was predicted that older individuals, as well as those who endorse 
more depression, negative affect, and pain catastrophizing would have a stronger 
relationship between sleep and pain. 
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CHAPTER 3 
 
METHOD 
Participants 
 Participants were 90 adults, aged 21 to 74, who were diagnosed with 
fibromyalgia (FM) and recruited as part of a National Institute of Health randomized 
clinical trial for FM interventions. Although this was a multi-center trial, including Wayne 
State University and the University of Michigan, the current data were taken solely from 
the Wayne State University site. There were 85 women (94.4%) and 5 men (5.6%), and 
they identified themselves as Caucasian (67.8%), African American (25.5%), or other 
(6.7%). Participants met the 1990 ACR criteria and/or the modified 2010 ACR FM 
criteria to be included in the study. Potential participants were excluded from the study if 
they had co-morbid autoimmune disorders (e.g., rheumatoid arthritis, systemic lupus 
erythematosus) or any other serious medical condition that could have impaired health 
status independently of FM including cardiopulmonary disorders (e.g. COPD, CHF), 
uncontrolled endocrine or allergic disorders, or malignancy within the previous 2 years. 
Other exclusion criteria included current psychotic disorder, dissociative identity 
disorder, alcohol or drug dependence in the past 2 years, or active suicide risk. 
Individuals with cognitive impairment or dementia, who were unable to fluently read or 
converse in English, or who had pending (or recently received) FM-related litigation, 
disability, or workman’s compensation were also excluded. 
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Procedure 
 Screening 
Participants recruited for the clinical trial were screened by telephone for FM 
symptoms, litigation/disability status, and co-morbid autoimmune disorders. Individuals 
who passed the telephone screening criteria and remained interested in participating 
were screened in person by the study coordinator.  
An in-person screening was conducted with each participant at a convenient 
location (i.e., Detroit, Farmington Hills, or Macomb). Participants completed the written 
informed consent document, approved by the Human Investigation Committee of 
Wayne State University. The study coordinator obtained demographic and medical 
history information and ensured that the participants met the diagnostic criteria for FM 
(Wolfe et al., 1990; Wolfe et al., 2010). Tender point counts were assessed with the 
standard procedure for applying pressure in the Manual Tender Point Survey (MTPS) 
using the thumb pad of the examiner’s dominant hand (Okifuji, Turk, Sinclair, Starz, & 
Marcus, 1997). The FM Symptom scale (FS) was also assessed by combining the 
Widespread Pain Index (WPI) and modified Symptom Severity scale (SS) as described 
in the modified ACR 2010 FM criteria (Wolfe et al., 2011). The participants completed a 
number of self-report measures not used in this dissertation and received $50 for the 
screening visit. 
 Baseline evaluation 
 Participants were asked to return for an in-person evaluation session conducted 
by a research assistant. Each participant was assessed for changes in health, 
medications, disability claims, and recent stressors since the screening visit. Those 
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participants who still met study inclusion criteria completed a battery of self-report 
measures, including the Center for Epidemiological Studies Depression Scale (CES-D; 
Radloff, 1977), Pain Catastrophizing Scale (PCS; Sullivan et al., 1995), Brief Pain 
Inventory (BPI; Cleeland & Ryan, 1994), Pittsburgh Sleep Quality Index (PSQI; Buysse, 
Reynolds, Monk, Berman, & Kupfer, 1989), Positive and Negative Affect Schedule 
(PANAS; Watson, Clark, & Tellegen, 1988) and others that were not used in this 
dissertation. The baseline evaluation also included experimental pain testing and heart 
rate variability (HRV) recording, neither of which was included in this dissertation. At the 
conclusion of the evaluation session, each participant was taught how to use an 
Actiwatch (Mini-Mitter, Respironics, Inc.) and was given one of these devices to wear for 
the following 2 weeks. In addition to wearing the Actiwatch, participants completed an 
activity log each day for the 2-week period (Appendix A). The activity log provided 
context for the movement data that was recorded with actigraphy. Participants were 
asked to record their average pain level for the entire day prior to bed each night. They 
also completed a set of morning questions upon awakening that pertained to the 
previous night’s sleep. These questions included what time the participants attempted to 
fall asleep, how long they took to fall asleep, what time they woke to begin their day, 
and how refreshed they felt after their previous night’s sleep. In addition, participants 
were requested to write down each time the Actiwatch was removed and for how long 
the device was off the wrist. The participants received $100 for the evaluation visit and 
$50 for returning the Actiwatch after 2 weeks. 
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Measures 
 Prospective Daily Measures 
 This dissertation assessed daily sleep and pain ratings recorded with the 
Actiwatch (Mini-Mitter, Respironics, Inc.) and activity log. 
 Actiwatch. The Actiwatch (Mini-Mitter, Respironics, Inc.) is a lightweight activity 
and movement monitor that is worn on the non-dominant wrist. It provides an objective 
behavioral measurement of sleep by recording activity throughout the day and night with 
an accelerometer. Participants wore this device for a 2-week period, and their activity 
data was translated into either “wake” or “sleep” based on a standard, validated 
algorithm that applies correction factors derived from polysomnography (Philips 
Respironics, 2009). The Actiware scoring software is both reliable and valid for 
estimating sleep statistics when compared with traditional laboratory methods of sleep 
measurement (Cellini, Buman, McDevitt, Ricker, & Mednick, 2013). Data was recorded 
in 1-minute epochs throughout the study period, and actigraphy data was cleaned and 
scored with reference to diary data obtained from the activity log. For example, the 
information written in the activity log regarding what time the participants attempted to 
fall asleep and what time the participants woke to start their day aided in creating 
accurate rest and active intervals. The time and duration that the participants wrote 
down for when the watch was removed also aided in creating accurate exclusion 
intervals. The cleaned and scored actigraphy data produced several sleep and wake 
statistics. The variables of interest for this study were time in bed (TIB; the number of 
minutes in the nighttime rest interval), sleep onset latency (SOL; the number of minutes 
scored as wake from the beginning of the nighttime rest interval until the initiation of 
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sleep), total sleep time (TST; the number of minutes during the nighttime rest interval 
scored as sleep), wake after sleep onset (WASO; the number of minutes within the TST 
interval scored as wake), and sleep efficiency (SE; the percentage of scored total sleep 
time to the time in bed interval).  
 Daily activity log. In addition to wearing the Actiwatch, participants were asked to 
complete a daily activity log with subjective sleep information and to rate their average 
daily pain severity. The activity log produced several self-reported sleep and wake 
statistics including time in bed (SRTIB), sleep onset latency (SRSOL), total sleep time 
(SRTST), wake after sleep onset (SRWASO), sleep efficiency (SRSE), and refresh 
score (RS; an indication of how refreshed the participant felt after the previous night’s 
sleep). Refresh score was measured on a scale from 0 to 10 where 0 represents “not at 
all refreshed” and 10 indicates “completely refreshed.” All of the self-reported sleep 
variables were recorded in the morning upon awakening.  Average pain was measured 
on a scale from 0 to 10 where 0 represents “no pain” and 10 indicates “pain as bad as 
you can imagine.” This daily value was recorded in the activity log as well as in the 
Actiwatch prior to bed each night.  
 Baseline Measures 
 Depression. The Center for Epidemiological Studies Depression Scale (CES-D; 
Radloff, 1977) contains 20 items that measure depressive symptomatology. Participants 
were instructed to focus on their depressed mood during the past week when 
completing the items. Each item was scored from 0 to 3 where 0 indicates “rarely or 
none of the time” and 3 represents “most or almost all the time.” The scale can be 
analyzed either as a continuous measure of depressive symptoms or as a dichotomous 
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measure, with scores of 16 or greater indicating symptom levels suggestive of 
depression. Normative studies of women scoring 16 or above on the CES-D have found 
rates between 8.7% and 17.4% (Knight, Williams, Mcgee & Olaman, 1997; Myers & 
Weissman, 1980; Roberts & Vernon, 1983). Several studies have found that the 
established cutoff of 16 for the CES-D overestimates the prevalence of depression in 
non-clinical samples (Beekman et al., 1997; Santor, Zuroff, Ramsay, Cervantes, & 
Palacios, 1995; Roberts, Lewinsohn, & Seeley, 1991). Therefore, a cutoff of 20 was 
used in this dissertation as an estimate of probable depression. The CES-D has also 
successfully been used to assess depression symptoms across wide age ranges 
(Lewinsohn, Seeley, Roberts, & Allen, 1997), an important consideration for the present 
dissertation. In this study, the CES-D demonstrated good reliability at baseline 
(Cronbach’s alpha = 0.70). 
 Pain Catastrophizing. The Pain Catastrophizing Scale (PCS; Sullivan et al., 
1995) contains 13 statements about pain. Participants were instructed to indicate the 
degree to which they have the thoughts and feelings listed when they experience pain, 
from 0 meaning “not at all” to 4 meaning “all the time.” The total scale is dichotomous 
with scores of 30 or greater indicating a clinically relevant level of catastrophizing. For 
this dissertation, a mean score of the 13 items was used to assess overall pain 
catastrophizing, and this scale demonstrated excellent reliability at baseline (Cronbach’s 
alpha = 0.93). 
 Brief Pain Inventory. A modified version of the Brief Pain Inventory (BPI; 
Cleeland & Ryan, 1994) was used in this dissertation. Participants were asked to 
answer four questions about their worst, least, and average pain over the past week, as 
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well as their current level of pain at the time of assessment. Each of these questions 
was scored on a 0 to 10 scale where 0 represents “no pain” and 10 indicates “pain as 
bad as you can imagine.” A mean score for all four pain severity items was calculated 
and utilized in analyses as an index of baseline pain, and this measure demonstrated 
good internal consistency (Cronbach’s alpha = 0.85). 
 Pittsburgh Sleep Quality Index. The Pittsburgh Sleep Quality Index (PSQI; 
Buysse et al., 1989) contains 19 self-rated questions related to usual sleep habits 
during the past month. These items were combined to form seven “component” scores 
(i.e., subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, 
sleep disturbances, use of sleeping medication, and daytime dysfunction), all of which 
were scored on a 0 to 3 scale where 0 indicates “no difficulty” and 3 represents “severe 
difficulty.” The seven component scores were added to yield a global PSQI score with a 
range of 0 to 21 points that was utilized in analyses as an index of baseline sleep 
quality. In this study, global PSQI demonstrated an acceptable level of reliability at 
baseline (Cronbach’s alpha = 0.64). 
 Positive and Negative Affect Schedule. The Positive and Negative Affect 
Schedule (PANAS; Watson et al., 1988) contains 20 words and phrases that describe 
different feelings and emotions. Participants were instructed to indicate to what extent 
they felt each descriptor over the past few weeks on a scale from 1 to 5 where 1 
represents “very slightly or not at all” and 5 indicates “extremely.” Mean positive affect 
and negative affect scores were calculated from the 10 words and phrases that loaded 
onto each construct. In this study, internal consistency was excellent for both positive 
affect (Cronbach’s alpha = 0.91) and negative affect (Cronbach’s alpha = 0.90). These 
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variables were utilized in analyses to determine if the depression variable (CES-D) 
assessed unique variance in addition to negative affect. 
Data Analysis 
The actigraphy data was cleaned and scored with reference to the daily activity 
log with subjective sleep information as noted previously. The resultant objective 
variables of time in bed (TIB), sleep onset latency (SOL), total sleep time (TST), wake 
after sleep onset (WASO), and sleep efficiency (SE) were used in the analyses. The 
subjective variables of time in bed (SRTIB), sleep onset latency (SRSOL), total sleep 
time (SRTST), wake after sleep onset (SRWASO), sleep efficiency (SRSE), and refresh 
score (RS) were also used in the analyses. 
 Multilevel modeling was utilized for this dissertation due to the hierarchical 
structure of the data (14 daily observations nested within persons). This methodology 
was able to account for within-person variation (a participant’s daily deviation from their 
own 14-day mean) and between-person variation (each participant’s deviation from the 
grand mean). In order to model both within- and between-person variation, each daily 
predictor variable was represented by two different variables (Hoffman & Stawski, 
2009). For each predictor, a within-person variable (Level 1) represented the deviation 
from that individual’s mean on a particular day. For each participant and predictor, a 
second between-person variable (Level 2) represented that individual’s average for the 
predictor across all days (person mean), and the variable was centered so that 0 was 
the grand mean. 
The data was checked for accuracy and frequency distributions. Several of the 
between-person predictor variables were skewed (average sleep onset latency, average 
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sleep efficiency, average self-report sleep onset latency, and average self-report wake 
after sleep onset). These variables were winsorized and average sleep onset latency 
and average self-report wake after sleep onset were log10(x+1) transformed. Results of 
correlational analyses did not differ between the original and the winsorized and 
transformed variables. Therefore, only original variables were used in subsequent 
analyses.  
Preliminary analyses assessed the relationships among the baseline predictor 
variables of depression, negative affect, pain catastrophizing, sleep quality, pain, and 
age. Analyses were also conducted to determine the relationships among the average 
objective and subjective sleep predictor variables.  
 Sleep/Pain Relationship 
 Two sets of analyses were conducted with multilevel modeling in order to 
determine the relationship between daily sleep and pain, each looking at the entire 
sample of participants. The first set of analyses described the relationship between the 
objective (actigraphy) and subjective (activity log) nightly sleep variables and the next 
day’s average pain. The second set of analyses described the relationship between 
average daily pain and the subsequent night’s objective and subjective sleep variables. 
These analyses addressed the hypothesis about the direction of the sleep / pain 
relationship. Analyses were also conducted with multilevel modeling in order to 
determine the relationship between the baseline predictor variables and sleep and pain 
outcomes.  
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 Potential Moderator Analysis 
 To determine what factors may be driving the sleep and pain correlation across 
individuals, the potential moderator variables of age, depression, negative affect, and 
pain catastrophizing were built into the multilevel model to determine if they were 
significant predictors of the relationship between sleep and pain and between pain and 
sleep. Each potential moderator was added as a continuous variable and was further 
described as a dichotomous variable when a significant interaction term resulted (e.g., 
older vs. younger, high vs. low depression, high vs. low negative affect, and high vs. low 
pain catastrophizing).  
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CHAPTER 4 
RESULTS 
Preliminary Analyses 
 Individuals were included in the analyses if they completed at least 7 days of 
actigraphy and daily sleep and pain diaries. Adherence for actigraphy was very high, 
with 83 individuals completing at least 12 of the 14 days (M = 13.24 days, SD = 1.34). 
Daily sleep and pain diary adherence was also very high, with 86 individuals completing 
at least 12 of the 14 days (M = 13.28 days, SD = 1.07). 
 Analyses were conducted to determine the relationships among the six baseline 
predictors: depression (CES-D; M = 20.20, SD = 10.97), negative affect (PANAS; M = 
2.01, SD = 0.74), pain catastrophizing (PCS; M = 1.39, SD = 0.84), sleep quality (PSQI; 
M = 12.32, SD = 3.99), pain (BPI; M = 5.63, SD = 1.82), and age (M = 50.24, SD = 
12.77). Table 1 presents the correlations among the baseline predictors.  As shown in 
this table, depression and negative affect were highly correlated, as expected (p < .01). 
The remainder of the self-reported variables (depression, negative affect, pain 
catastrophizing, sleep quality, and pain) were all positively correlated, with most 
correlations ranging from r = .26 to r = .49. Interestingly, baseline pain was not 
significantly related to baseline depression or negative affect.  Age was inversely 
correlated with the other five predictors, with correlations ranging from r = -.16 to r =       
-.30.  
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Table 1 
Correlations among the Baseline Predictor Variables  
 2 3 4 5 6 
1. Depression (CESD) .79** .49** .42** .14 -.16 
2. Negative Affect (PANAS) --- .33** .26* .06 -.21 
3. Pain Catastrophizing (PCS)  --- .26* .35** -.30** 
4. Sleep Quality (PSQI)   --- .35** -.16 
5. Pain (BPI)    --- -.19 
6. Age     --- 
Note. All correlations were 2-tailed. 
*p < .05. **p < .01. 
 
 Analyses were also conducted to determine the relationships among the daily 
objective and subjective sleep outcome variables: time in bed (TIB; M = 495.71 min, SD 
= 64.10), sleep onset latency (SOL; M = 16.81 min, SD = 15.80), wake after sleep onset 
(WASO; M = 65.92 min, SD = 24.47), total sleep time (TST; M = 401.16 min, SD = 
57.52), sleep efficiency (SE; M = 80.47%, SD = 8.85), refresh score (RS; M = 4.0, SD = 
1.78), self-report time in bed (SRTIB; M = 500.73 min, SD = 65.42), self-report sleep 
onset latency (SRSOL; M = 27.37 min, SD = 20.31), self-report wake after sleep onset 
(SRWASO; M = 36.74 min, SD = 34.32), self-report total sleep time (SRTST; M = 
440.05 min, SD = 53.85), and self-report sleep efficiency (SRSE; M = 88.09%, SD = 
7.39). These descriptive analyses represent the average of each of these daily variables 
across the 14 days of data collection. 
 Table 2 presents the correlations among the average daily sleep variables.  As 
shown in this table, the subjective measures were more highly correlated with one 
another than the objective measures. Importantly, the sleep variables were related to 
one another in similar patterns (e.g., as time in bed (TIB) increased, total sleep time 
(TST) also increased). Although not significant for either subjective or objective sleep, 
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the one exception to the predictable pattern of correlations was found between sleep 
onset latency (SOL) and TST; a negative relationship for objective sleep, and a positive 
relationship for subjective sleep.  
 The objective outcome variables of time in bed (TIB), wake after sleep onset 
(WASO), and total sleep time (TST), were significantly correlated with their subjective, 
self-reported counterparts (p < .01). In contrast, the objective outcome variables of 
sleep onset latency (SOL) and sleep efficiency (SE) were not significantly related to 
their subjective counterparts. Although self-reported refresh score was significantly 
related to other self-reported sleep variables, how refreshed one feels upon awakening 
was not significantly correlated with any objective sleep variables.  
Table 2 
Correlations among the Average Daily Sleep Variables  
 2 3 4 5 6 7 8 9 10 11 
1. Time in Bed .17 .45† .80† -.03 -.20 .95† .54† .43† .68† -.42† 
2. Sleep Onset Latency --- .19 -.11 -.70† -.03 .23* .17 .01 .22* -.05 
3. Wake After Sleep Onset  --- -.10 -.54† -.12 .50† .29† .46† .25* -.41† 
4. Total Sleep Time   --- .39† -.11 .72† .41† .21* .57† -.23* 
5. Sleep Efficiency    --- .04 -.11 -.01 -.19 -.03 .14 
6. Refresh Score     --- -.24* -.28† -.25* -.04 .32 
7. Self-report Time in Bed      --- .55† .43† .74† -.41† 
8. Self-report Sleep Onset 
Latency       --- .37
†
 .07 -.65† 
9. Self-report Wake After 
Sleep Onset        --- -.18 -.87
†
 
10. Self-report Total Sleep 
Time         --- .29
†
 
11. Self-report Sleep 
Efficiency          --- 
Note. All correlations were 2-tailed. 
*p < .05. †p < .01. 
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 Each of the Level 1 (within-person) outcome variables of sleep and pain was 
then tested to determine if they differed significantly across individuals, that is, whether 
participants differed from one another on the daily sleep and pain variables, which is a 
prerequisite for further HLM analyses. These were conducted with the intercept-only 
model in HLM, which is the equivalent to a one-way, random-effects ANOVA model 
(Table 3).  
Table 3 
HLM One-Way Random Effects ANOVA Model   
Equations Example  
Level 1 Model    Level 1 Model     
     Yij = β0j + rij      PS = β0j + rij  
Level 2 Model Level 2 Model  
     β0j = γ00 + u0j      β0j = γ00 + u0j  
Mixed Model Mixed Model  
     Yij = γ00 + u0j + rij      PS = γ00 + u0j + rij  
Note. Equations are from Raudenbush and Bryk (2002); PS = Daily pain score 
 All of the objective and subjective sleep variables as well as daily pain were 
significantly different across individuals (p<.001). This signaled that further HLM 
analyses were indicated because there was sufficient variation among participants to 
warrant an analytic method that would assess daily variation within- and between-
individuals. Intraclass correlation coefficients (ρ = τ00 / (τ00 + σ2) were also calculated to 
determine the percentage of the variance in each outcome variable that was between 
individuals (Table 4). The variation between individuals for the objective and subjective 
sleep variables of time in bed, sleep onset latency, wake after sleep onset, total sleep 
time, and sleep efficiency ranged from 15.3 to 45.1%, indicating that over half of the 
variance was found within individuals. In contrast, refresh score and daily pain score 
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had intraclass correlation coefficients that were 58.3 and 64.4% respectively, indicating 
that there was more variance between- than within-individuals for these variables. 
Table 4 
Intraclass Correlation Coefficients (ICC) for Each Outcome Variable 
 
 
Intraclass Correlation Coefficient 
(ICC) / % of variance 
Objective Variables   
     Time in Bed (TIB) ρ = 0.306 / 30.6% * 
     Sleep Onset Latency (SOL) ρ = 0.153 / 15.3% * 
     Wake After Sleep Onset (WASO) ρ = 0.357 / 35.7% * 
     Total Sleep Time (TST) ρ = 0.318 / 31.8% * 
     Sleep Efficiency (SE) ρ = 0.451 / 45.1% * 
Subjective Variables       
     Self-report Time in Bed (SRTIB) ρ = 0.321 / 32.1% * 
     Self-report Sleep Onset Latency (SRSOL) ρ = 0.272 / 27.2% * 
     Self-report Wake After Sleep Onset (SRWASO) ρ = 0.334 / 33.4% * 
     Self-report Total Sleep Time (SRTST) ρ = 0.184 / 18.4% * 
     Self-report Sleep Efficiency (SRSE) ρ = 0.267 / 26.7% * 
     Refresh Score (RS) ρ = 0.583 / 58.3% * 
     Daily Pain Score (PS) ρ = 0.644 / 64.4% * 
*p < .001. 
 
Primary Analyses 
 The intercept-only models indicated the appropriateness of further HLM 
analyses. Two sets of primary analyses were conducted. The first analyzed the daily 
objective and subjective sleep variables as predictors of next day’s pain score. The 
second set of analyses evaluated daily pain on the next night’s objective and subjective 
sleep variables. For each daily predictor variable, two different variables were entered 
into the model to account for both within- and between-person variation (Hoffman & 
Stawski, 2009; Table 5).  
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Table 5 
HLM Random Coefficient Model   
Equations Example 
Level 1 Model    Level 1 Model    
     Yij = β0j + β1j(XWP) +  rij      PS = β0j + β1j(TIBWP) +  rij 
Level 2 Models Level 2 Models 
     β0j = γ00 + γ01(XBP) +  u0j      β0j = γ00 + γ01(TIBBP) +  u0j 
     β1j = γ10 + u1j      β1j = γ10 + u1j 
Mixed Model Mixed Model 
Yij = γ00 + γ01(XBP) +  γ10(XWP) + u0j + u1j(XWP) + 
rij 
PS = γ00 + γ01(TIBBP) +  γ10(TIBWP) + u0j + 
u1j(TIBWP) + rij 
Note. Equations are from Raudenbush and Bryk (2002); WP = within-person; BP = between-person; PS = 
Daily pain score; TIB = Time in Bed 
 
 Sleep Variables Predicting Next Day’s Pain  
  Each objective (actigraphy) and subjective (activity log) sleep predictor variable 
was entered into the model individually. This included a within-person variable (Level 1) 
that indicated the deviation from that individual’s mean on a particular day, and a 
between-person variable (Level 2) that represented that individual’s average for the 
predictor across all days.  
 As shown in Table 6, objective and subjective sleep did not impact next day’s 
pain in general (between-person), except for wake after sleep onset (WASO). In other 
words, there was not a significant difference between individuals for the relationship of 
average objective and subjective sleep variables (Level 2) on daily pain (Level 1), 
except for average WASO. Individuals who had more WASO on average experienced 
increased daily pain. Similarly, each participant’s daily objective and subjective sleep 
did not impact their experience of pain the following day (within-person), except for self-
reported refresh score (RS). Participants who reported less than their average refresh 
score upon awakening experienced more pain the next day.  
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Table 6 
 
Relationship of Objective and Subjective Sleep Predictor Variables on Next Day Pain 
Ratings 
 
 
 Daily Pain Outcome 
 Between-Person Within-Person 
Objective Predictor Variables  (Level 2) (Level 1) 
     Time in Bed (TIB) -0.0008 (0.0026) 0.0002 (0.0005) 
     Sleep Onset Latency (SOL) 0.0057 (0.0092) 0.0008 (0.0014) 
     Wake After Sleep Onset (WASO) 0.0140 (0.0061)* 0.0001 (0.0015) 
     Total Sleep Time (TST) -0.0046 (0.0030) 0.0002 (0.0005) 
     Sleep Efficiency (SE) -0.0288 (0.0186) -0.0008 (0.0048) 
Subjective Predictor Variables        
     Self-report Time in Bed (SRTIB) -0.0006 (0.0026) -0.0000 (0.0004) 
     Self-report Sleep Onset Latency (SRSOL) -0.0066 (0.0083) 0.0015 (0.0012) 
     Self-report Wake After Sleep Onset (SRWASO) 0.0065 (0.0057) 0.0007 (0.0010) 
     Self-report Total Sleep Time (SRTST) -0.0020 (0.0038) -0.0002 (0.0004) 
     Self-report Sleep Efficiency (SRSE) -0.0134 (0.0254) -0.0024 (0.0034) 
     Refresh Score (RS) -0.0884 (0.0996) -0.1326 (0.0364)** 
Note. Parameter estimates are unstandardized beta coefficients, with SE in parentheses. 
** p = .001,  *p < .05. 
 
Daily Pain Predicting Next Night’s Sleep 
 Each objective (actigraphy) and subjective (activity log) sleep variable was 
entered into the model individually as the outcome variable. Daily pain was then added 
as the predictor variable, including a within-person variable (Level 1) that indicated the 
deviation from that individual’s mean pain score on a particular day, and a between-
person variable (Level 2) that represented that individual’s average pain score across all 
days.  
 As shown in Tables 7 and 8, average daily pain did not impact the next night’s 
objective and subjective sleep in general (between-person), except for wake after sleep 
onset (WASO). Individuals who reported greater daily pain on average experienced 
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increased nightly WASO. Similarly, each participant’s daily pain did not impact their 
objective and subjective sleep the following night (within-person), except for self-
reported sleep onset latency (SRSOL). Participants who reported more than their 
average pain one day experienced a greater latency to sleep the following night.  
Table 7 
 
Relationship of Daily Pain Score Predictor on Objective Sleep Outcome Variables 
 
 Time in Bed 
(TIB) 
Sleep Onset 
Latency 
(SOL) 
Wake After 
Sleep Onset 
(WASO) 
Total Sleep 
Time (TST) 
Sleep 
Efficiency 
(SE) 
Daily Pain 
Score BP -1.56 (3.83) 0.32 (0.87) 2.99 (1.29)* -6.03 (3.81) -0.79 (0.45) 
Daily Pain 
Score WP -0.24 (2.25) 0.38 (0.75) 0.62 (0.81) 0.03 (2.09) -0.01 (0.21) 
Note. Parameter estimates are unstandardized beta coefficients, with SE in parentheses. BP = Between-
person (Level 2); WP = Within-person (Level 1) 
 *p < .05. 
 
Table 8 
 
Relationship of Daily Pain Score Predictor on Subjective Sleep Outcome Variables 
 
 
Self-Report 
Time in 
Bed 
(SRTIB) 
Self-Report 
Sleep 
Onset 
Latency 
(SRSOL) 
Self-Report 
Wake After 
Sleep 
Onset 
(SRWASO) 
Self-Report 
Total Sleep 
Time 
(SRTST) 
Self-Report 
Sleep 
Efficiency 
(SRSE) 
Refresh 
Score  
(RS) 
Daily Pain 
Score BP -1.28 (3.99) -0.68 (1.35) 3.06 (2.20) -1.98 (3.51) -0.24 (0.49) -0.09 (0.11) 
Daily Pain 
Score WP 0.05 (2.70) 1.35 (0.68)* -0.01 (1.08) -0.94 (2.83) -0.18 (0.25) -0.03 (0.04) 
Note. Parameter estimates are unstandardized beta coefficients, with SE in parentheses. BP = Between-
person (Level 2); WP = Within-person (Level 1) 
 *p < .05. 
 
Level 2 Baseline Measures Predicting Daily Pain Outcome across Individuals 
 In addition to evaluating the impact of sleep variables on next day’s pain, Level 2 
baseline measures of depression, negative affect, sleep quality, age, and pain 
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catastrophizing, were each built into the intercepts- and slopes-as-outcomes model 
individually to determine their effect on daily pain across individuals (Table 9). 
Table 9 
HLM Intercepts- and Slopes-as-Outcomes Model with a Level 2 Predictor Only   
Equations Example 
Level 1 Model    Level 1 Model    
     Yij = β0j +  rij      PS = β0j + rij 
Level 2 Model Level 2 Model 
     β0j = γ00 + γ01(Wj) +  u0j      β0j = γ00 + γ01(CESD) +  u0j 
Mixed Model Mixed Model 
Yij = γ00 + γ01(Wj) + u0j + rij PS = γ00 + γ01(CESD) + u0j + rij 
Note. Equations are from Raudenbush and Bryk (2002); PS = Daily pain score; CESD = Depression total 
score 
 
 As shown in Table 10, baseline depression, negative affect, and sleep quality did 
not significantly predict daily pain across individuals. Age was a significant predictor of 
daily pain, such that individuals who were older reported less pain, on average, than 
those who were younger. Baseline pain catastrophizing was also a significant predictor 
of daily pain, such that individuals who reported greater levels of catastrophizing about 
their pain reported more pain, on average, than those individuals who reported less 
catastrophizing. 
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Table 10 
 
Relationship of Baseline Predictors on Daily Pain Outcome across Individuals 
 
 Daily Pain Score 
Depression (CESD) 0.02 (0.02) 
Negative Affect (PANAS) 0.15 (0.28) 
Sleep Quality (PSQI) 0.09 (0.04) 
Age -0.05 (0.01)** 
Pain Catastrophizing (PCS) 0.74 (0.18)*** 
Note. Parameter estimates are unstandardized beta coefficients, with SE in parentheses. 
***p < .001, **p = .001 
 
Level 2 Baseline Measures Predicting Objective and Subjective Sleep Outcome 
Variables across Individuals 
 In addition to evaluating the impact of daily pain scores on the next night’s sleep 
variables, Level 2 baseline measures of depression, negative affect, pain 
catastrophizing, pain, and age were each built into the intercepts- and slopes-as-
outcomes model individually to determine their effect on objective and subjective sleep 
variables across individuals. 
 As shown in Tables 11 and 12, baseline negative affect did not significantly 
predict objective or subjective sleep outcome variables across individuals. Depression 
was a significant predictor of objective time in bed (TIB) as well as most of the 
subjective sleep variables (i.e., self-reported time in bed, self-reported sleep onset 
latency, self-reported wake after sleep onset, self-reported sleep efficiency, and refresh 
score). Individuals who reported higher levels of baseline depression spent more time in 
bed objectively, and reported that they spent more time in bed, took longer to fall 
asleep, spent more time awake during the night, and had a lower sleep efficiency than 
37 
 
 
those individuals who reported lower levels of depression. In addition, the individuals 
who reported higher levels of baseline depression reported feeling less refreshed upon 
awakening than those who reported lower levels of depression.  
 Baseline pain was a significant predictor of refresh score (RS), such that 
individuals who reported greater baseline pain also reported feeling less refreshed upon 
awakening than individuals who reported lower levels of baseline pain. Age was a 
significant predictor of objective sleep onset latency (SOL), such that individuals who 
were older took longer to fall asleep than those who were younger. Lastly, baseline pain 
catastrophizing was a significant predictor of objective wake after sleep onset (WASO) 
and subjective time in bed (SRTIB). Individuals who reported greater levels of 
catastrophizing about their pain spent more time awake during the night and reported 
spending more time in bed than those individuals who reported lower levels of pain 
catastrophizing. 
Table 11 
 
Relationship of Baseline Predictors on Objective Sleep Variables across Individuals 
 
 Time in Bed 
(TIB) 
Sleep Onset 
Latency 
(SOL) 
Wake After 
Sleep Onset 
(WASO) 
Total Sleep 
Time (TST) 
Sleep 
Efficiency 
(SE) 
Depression 
(CESD) 1.57 (0.69)* -0.10 (0.11) 0.41 (0.24) 1.31 (0.67) 0.01 (0.07) 
Negative Affect 
(PANAS) 7.48 (10.77) -3.37 (2.08) -0.48 (3.71) 13.95 (9.41) 1.74 (0.98) 
Pain 
(BPI) 1.35 (3.42) 0.44 (0.82) 2.29 (1.33) -2.41 (3.84) -0.56 (0.48) 
Age 0.27 (0.48) 0.30 (0.11)† -0.07 (0.20) 0.12 (0.47) -0.04 (0.06) 
Pain 
Catastrophizing 
(PCS)
 
8.25 (5.46) -0.93 (1.67) 6.09 (2.97)* 2.54 (6.03) -0.90 (0.84) 
Note. Parameter estimates are unstandardized beta coefficients, with SE in parentheses.  
*p < .05, †p < .01. 
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Table 12 
 
Relationship of Baseline Predictors on Subjective Sleep Variables across Individuals 
 
 
Self-Report 
Time in 
Bed 
(SRTIB) 
Self-Report 
Sleep 
Onset 
Latency 
(SRSOL) 
Self-Report 
Wake After 
Sleep 
Onset 
(SRWASO) 
Self-
Report 
Total 
Sleep 
Time 
(SRTST) 
Self-Report 
Sleep 
Efficiency 
(SRSE) 
Refresh 
Score  
(RS) 
Depression 
(CESD) 1.69 (0.73)* 0.63 (0.27)* 0.84 (0.42)* 0.39 (0.57) -0.19 (0.09)* -0.03 (0.02)* 
Negative Affect 
(PANAS) 7.10 (11.32) 5.67 (3.74) 3.04 (5.98) 0.57 (8.94) -0.82 (1.23) -0.22 (0.24) 
Pain 
(BPI) 2.26 (3.39) 0.67 (1.07) 3.78 (1.95) -1.33 (3.32) -0.74 (0.45) -0.25 (0.10)* 
Age 0.30 (0.48) 0.03 (0.14) -0.26 (0.30) 0.47 (0.48) 0.03 (0.07) 0.02 (0.02) 
Pain 
Catastrophizing 
(PCS)
 
11.82 (5.66)* 1.65 (1.92) 3.62 (4.80) 6.81 (6.88) -0.68 (1.07) -0.31 (0.26) 
Note. Parameter estimates are unstandardized beta coefficients, with SE in parentheses.  
*p < .05. 
 
Moderator Analyses 
 Two sets of moderator analyses were conducted. The first analyzed the potential 
moderator variables of age, depression, negative affect, and pain catastrophizing to 
determine if each individually predicted the relationship between daily objective and 
subjective sleep variables and next day’s pain. The second set of analyses evaluated 
the same potential moderator variables to determine if each individually predicted the 
relationship between daily pain and the next night’s objective and subjective sleep 
variables. Each potential moderator was individually added to the intercepts- and 
slopes-as-outcomes model as a continuous variable, and was further described as a 
dichotomous variable when a significant interaction term resulted (Preacher, Curran, & 
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Bauer, 2006; Table 13). Only those moderator analyses that resulted in a significant 
interaction are presented below. 
Table 13 
HLM Intercepts- and Slopes-as-Outcomes Model  
Equations Example 
Level 1 Model    Level 1 Model    
     Yij = β0j + β1j(XWP) +  rij      PS = β0j + β1j(TIBWP) +  rij 
Level 2 Models Level 2 Models 
     β0j = γ00 + γ01(XBP) +  γ02(Wj) + u0j      β0j = γ00 + γ01(TIBBP) +  γ02(Age) + u0j 
     β1j = γ10 + γ11(Wj) + u1j      β1j = γ10 + γ11(Age) + u1j 
Mixed Model Mixed Model 
Yij = γ00 + γ01(XBP) +  γ02(Wj) + γ10(XWP) + 
γ11(Wj)(XWP) + u0j + u1j(XWP) + rij 
PS = γ00 + γ01(TIBBP) +  γ02(Age) + γ10(TIBWP) + 
γ11(Age)(TIBWP) + u0j + u1j(TIBWP) + rij 
Note. Equations are from Raudenbush and Bryk (2002); WP = within-person; BP = between-person; PS = 
Daily pain score; TIB = Time in Bed 
 
 Moderators of the Relationship between Sleep and Next Day’s Pain 
 Age was a significant moderator of the relationship between subjective sleep 
onset latency (SOL) and the next day’s pain. Figure 1 indicates that there is a stronger, 
positive relationship between subjective SOL and next day’s pain for individuals who are 
older (β = 0.004 (0.002), p=0.04), compared with the negative relationship between 
subjective SOL and next day’s pain for younger individuals (β = -0.002 (0.002), p=0.52). 
In addition to the fact (noted above in Table 10), that older individuals have significantly 
lower daily pain than younger people, the interaction indicates that this finding is more 
pronounced for individuals with shorter subjective sleep onset latency the previous night 
compared with those who report longer sleep onset latency. 
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Figure 1. Interaction of daily self-report sleep onset latency (SOL) and age on the next 
day’s pain score. Younger and older participants were -1SD and +1SD of the mean 
respectively. Daily self-report sleep onset latency was centered around a mean of zero. 
 Depression was a significant moderator of the relationship between refresh score 
and next day’s pain. Figure 2 indicates that there is a stronger, negative relationship 
between self-reported refreshing quality of sleep and next day’s pain for individuals who 
reported higher levels of baseline depression (β = -0.23 (0.05), p=0.0) than for those 
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who reported lower levels of baseline depression (β = -0.04 (0.05), p=0.50). In addition 
to the fact (noted above in Table 10), that individuals who reported higher levels of 
depression have greater daily pain than those who reported lower levels of depression, 
the interaction indicates that this finding is more pronounced for individuals who report 
less refreshing quality of sleep from the previous night compared with those who report 
more refreshing quality of sleep.  
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Figure 2. Interaction of daily refresh score and baseline depression on the next day’s 
pain score. Low and high depression were -1SD and +1SD of the mean respectively. 
Daily refresh score was centered around a mean of zero. 
 Negative affect was also a significant moderator of the relationship between 
refresh score and next day’s pain. Similar to the findings with depression, Figure 3 
indicates that there is a stronger, negative relationship between self-reported refreshing 
quality of sleep and next day’s pain for individuals who reported higher levels of 
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baseline negative affect (β = -0.22 (0.05), p=0.0) than for those who reported lower 
levels of baseline negative affect (β = -0.04 (0.05), p=0.41). In addition to the fact (noted 
above in Table 10), that individuals who reported higher levels of negative affect have 
greater daily pain than those who reported lower levels of negative affect, the interaction 
indicates that this finding is more pronounced for individuals who report less refreshing 
quality of sleep from the previous night compared with those who report more refreshing 
quality of sleep.  
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Figure 3. Interaction of daily refresh score and baseline negative affect on the next 
day’s pain score. Low and high negative affect were -1SD and +1SD of the mean 
respectively. Daily refresh score was centered around a mean of zero. 
 Negative affect was a significant moderator of the relationship between objective 
total sleep time (TST) and next day’s pain. Figure 4 indicates that there is a small, 
negative relationship between objective TST and next day’s pain for individuals who 
reported higher levels of baseline negative affect (β = -0.0007 (0.0007), p=0.30), 
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compared with a small, positive relationship between objective TST and next day’s pain 
for those who reported lower levels of baseline negative affect (β = 0.001 (0.0008), 
p=0.13). In addition to the fact (noted above in Table 10), that individuals who reported 
higher levels of negative affect have greater daily pain than those who reported lower 
levels of negative affect, the interaction indicates that this finding is more pronounced 
for individuals who report less total sleep time the previous night compared with those 
who report more total sleep time. 
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Figure 4. Interaction of objective daily total sleep time (TST) and baseline negative 
affect on the next day’s pain score. Low and high negative affect were -1SD and +1SD 
of the mean respectively. Daily total sleep time was centered around a mean of zero. 
 Pain catastrophizing was found to be a significant moderator of the relationship 
between objective sleep efficiency (SE) and next day’s pain. Figure 5 indicates that 
there is a small, negative relationship between objective SE and next day’s pain for 
individuals who reported higher levels of baseline pain catastrophizing (β = -0.0099 
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(0.007), p=0.16), and an almost equal positive relationship between objective SE and 
next day’s pain for those who reported lower levels of baseline pain catastrophizing (β = 
0.0097 (0.008), p=0.24). In addition to the fact (noted above in Table 10), that 
individuals who reported higher levels of pain catastrophizing have greater daily pain, 
the interaction indicates that this finding is more pronounced for individuals with less 
objective sleep efficiency the previous night compared with those who have greater 
objective sleep efficiency.  
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Figure 5. Interaction of objective daily sleep efficiency (SE) and baseline pain 
catastrophizing on the next day’s pain score. Low and high pain catastrophizing were -
1SD and +1SD of the mean respectively. Daily sleep efficiency was centered around a 
mean of zero. 
 
Moderators of the Relationship between Daily Pain and the Next Night’s Sleep 
 Age was a significant moderator of the relationship between daily pain and the 
next night’s subjective sleep onset latency (SOL). Figure 6 indicates that there is a 
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stronger, positive relationship between daily pain and the next night’s subjective SOL for 
individuals who are older (β = 2.49 (1.10), p=0.03) compared with those who are 
younger (β = 0.09 (1.16), p=0.94). In addition to the fact (noted above in Table 12), that 
older individuals have greater self-reported sleep onset latency than younger people, 
the interaction indicates that this finding is more pronounced for individuals who report 
higher levels of pain the previous day compared with those who report lower levels of 
pain. 
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Figure 6. Interaction of daily pain score and age on the next night’s self-report sleep 
onset latency (SOL). Younger and older participants were -1SD and +1SD of the mean 
respectively. Daily pain score was centered around a mean of zero. 
 Depression was a significant moderator of the relationship between daily pain 
and refresh score upon awakening the next morning. Figure 7 indicates that there is a 
stronger, negative relationship between daily pain and the next night’s refreshing quality 
of sleep for individuals who reported higher levels of baseline depression (β = -0.13 
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(0.06), p=0.03), compared with the positive relationship between daily pain and next 
night’s refreshing quality of sleep for individuals who reported lower levels of baseline 
depression (β = 0.07 (0.06), p=0.24). In addition to the fact (noted above in Table 12), 
that individuals who reported higher levels of depression also reported significantly 
lower refreshing quality of sleep than those who reported lower levels of depression, the 
interaction indicates that this finding is more pronounced for individuals who report 
higher levels of pain the previous day compared with those who report lower levels of 
pain. 
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Figure 7. Interaction of daily pain score and baseline depression on the next day’s 
refresh score. Low and high depression were -1SD and +1SD of the mean respectively. 
Daily pain score was centered around a mean of zero. 
 
 Lastly, pain catastrophizing was found to be a significant moderator of the 
relationship between daily pain and the next night’s objective sleep efficiency (SE). 
Figure 8 indicates that there is a negative relationship between daily pain and objective 
SE for individuals who reported higher levels of baseline pain catastrophizing (β = -0.45 
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(0.28), p=0.11), compared with the positive relationship between daily pain and 
objective SE for individuals who reported lower levels of baseline catastrophizing (β = 
0.42 (0.29), p=0.15). In addition to the fact (noted above in Table 11), that individuals 
who reported higher levels of pain catastrophizing have lower objective sleep efficiency 
than those who reported decreased levels of pain catastrophizing, the interaction 
indicates that this finding is more pronounced for individuals who report higher levels of 
pain the previous day compared with those who report lower levels of pain. 
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Figure 8. Interaction of daily pain score and baseline pain catastrophizing on the next 
night’s objective sleep efficiency (SE). Low and high pain catastrophizing were -1SD 
and +1SD of the mean respectively. Daily pain score was centered around a mean of 
zero. 
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CHAPTER 5 
DISCUSSION 
 This dissertation sought to examine the daily relationship between sleep and pain 
in a large population of chronic pain patients with fibromyalgia (FM), as well as the 
factors that may explain individual differences in this relationship. This study utilized 
actigraphy, an objective measurement of sleep, in addition to self-report daily sleep 
diaries. Few studies that have examined the daily sleep and pain relationship have 
included an objective measurement of sleep (O’Brien et al., 2011; Tang et al., 2012). In 
addition, these previous studies have failed to show a clear relationship between pain 
and objectively measured sleep, which may, in part, be due to evaluating populations 
that are very heterogeneous with respect to type of pain condition. In this study, 
participants with FM wore an actiwatch for two weeks while also completing daily diaries 
about their sleep and pain. The constructs of depression, negative affect, pain, sleep 
disturbance, and pain catastrophizing were assessed at baseline and tested as 
moderators of the daily sleep-pain relationship.  
 As mentioned previously, poor sleep quality is highly prevalent among individuals 
with FM, and is often characterized as light and unrefreshing (Moldofsky, 2008). An 
extensive literature of polysomnographic sleep studies has identified common sleep 
disturbances in this population including delayed sleep onset (Branco, Atalaia, & Paiva, 
1994; Horne & Shackell, 1991), increased arousals (Jennum, Drewes, Andreasen, & 
Nielsen, 1993), and lower total sleep time (Harding & Lee-Chiong, 2006) compared with 
healthy controls. Self-report is the most common methodology of studying sleep in FM 
through the use of sleep diaries and questionnaires such as the PSQI (Buysse et al., 
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1989). Similar to the study by O’Brien and colleagues (2011), the FM population in this 
dissertation reported longer sleep onset latency and shorter wake after sleep onset than 
was objectively measured with actigraphy. Total sleep time and sleep efficiency in the 
current study were similar to prior FM samples as well as healthy controls, suggesting 
that the nonrestorative aspect of sleep in the FM population may be due to perceived 
quality of sleep rather than amount of actual sleep obtained (Okifuji & Hare, 2011). The 
current FM sample also responded similarly to previous FM populations on the PSQI 
(Bigatti et al., 2008; Hamilton et al., 2012; O’Brien et al., 2010), providing further support 
for the representativeness of the current sample. 
The Daily Sleep and Pain Relationship 
 The first aim of this study was to determine the direction of the sleep and pain 
relationship among a sample of participants with FM. Recent reviews of the literature 
have established the connection between sleep and pain, although the direction of this 
relationship remains unclear (Finan et al., 2013; Moldofsky, 2001). In addition, FM is 
characterized by chronic widespread pain, and over 90% of individuals with this 
condition report poor sleep quality (Moldofsky, 2008; Wolfe et al., 1990). Therefore, this 
study sought to evaluate the direction of the daily sleep and pain relationship within this 
population.  
 In order to examine the intraindividual variability in daily sleep and pain among 
participants, hierarchical linear modeling (HLM) was utilized to analyze the daily 
objective and subjective sleep variables as predictors of next day’s pain, as well as daily 
pain on the next night’s objective and subjective sleep variables. This methodology 
accounted for between-person variation (each participant’s deviation from the grand 
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mean) and within-person variation (a participant’s daily deviation from their own 14-day 
mean), a process that reduced bias and more accurately reflected the relationship 
between daily measures and individual differences (Hoffman & Stawski, 2009). I will 
begin by discussing the average, between-person analyses of sleep and pain, as well 
as how the baseline predictors of depression, negative affect, sleep quality, pain, age, 
and pain catastrophizing predicted the daily sleep and pain outcome variables. I will 
then transition to the within-person analyses and discuss how these speak to the 
direction of the sleep and pain relationship. 
 Between-Person Sleep and Pain 
 For each participant and sleep predictor, a between-person variable representing 
that individual’s average for the predictor across all days (person mean) was analyzed 
to determine if there was an impact on daily pain. Individuals who had more objectively-
measured wake after sleep onset (WASO), averaged across days, experienced 
increased daily pain. Average pain across all 14 days was also analyzed to determine if 
there was an impact on the nightly objective and subjective sleep variables. Individuals 
who reported greater daily pain, averaged across days, experienced increased nightly 
objective WASO. These results provide further support for the relationship between 
sleep and pain and are also consistent with the literature that the most common sleep 
complaint of individuals with chronic pain is multiple awakenings (Taylor et al., 2007), 
and disruption of continuous sleep is more predictive of next day pain (Smith et al., 
2007). However, average, between-person analyses do not speak to the direction of the 
sleep and pain relationship. Therefore, within-person, daily analyses are needed, which 
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will be addressed after discussing the between-person analyses of baseline predictors 
on sleep and pain. 
 Between-Person Baseline Predictors on Sleep and Pain 
 In addition to the established literature linking sleep and pain, several other 
variables have been shown to significantly relate to pain, sleep, or both (Edwards et al., 
2006, Goodin et al., 2011, Lunde et al., 2010, Miró et al., 2011). Therefore, the baseline 
predictors of depression, negative affect, sleep quality, pain, age, and pain 
catastrophizing were each analyzed to determine if they significantly predicted the daily 
sleep and pain outcome variables. Age was found to be a significant predictor of daily 
pain, such that older individuals reported less pain, on average, than those who were 
younger. This is consistent with a recent correlational study that evaluated the 
association between aging and pain complaints among emergency room patients 
(Marco, Nagel, Klink, & Baehren, 2012). One explanation for this finding is that older 
individuals may perceive pain as part of the aging process and therefore underreport 
their pain (Klinger & Spaulding, 1998). Age was also a significant predictor of objective 
(actigraphy) sleep onset latency (SOL), such that individuals who were older took longer 
to fall asleep than those who were younger. This finding is consistent with a much larger 
body of literature on the relationship of sleep and aging. Research with both objective 
and self-report measures has found that older individuals take longer to fall asleep, 
spend more time awake during the night, and have decreased sleep efficiency (Lunde 
et al., 2010). In addition, the sleep of older individuals has been characterized as lighter 
and less refreshing than those who are younger, a description that has also been used 
to describe the sleep of individuals with FM (Crowley, 2011; Moldofsky, 2008). 
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 Baseline pain catastrophizing was found to be a significant predictor of daily pain, 
such that individuals who reported greater levels of catastrophizing about their pain 
reported more daily pain, on average, than those who reported less catastrophizing. 
This finding is also consistent with the significant positive correlation between baseline 
pain catastrophizing and baseline pain, suggesting that those individuals who report 
more catastrophizing about their pain are more likely to report greater levels of pain 
both retrospectively and prospectively. Indeed, these findings support the substantial 
literature linking pain catastrophizing with a heightened pain experience. Diverse patient 
groups have displayed this relationship between pain catastrophizing and pain, 
including mixed chronic pain, rheumatoid arthritis, low back pain, and fibromyalgia 
(Edwards et al., 2006; Flor, Behle, & Birbaumer, 1993; Severeijns et al., 2001; Sullivan 
et al., 2001). Research has also shown that catastrophizing accounts for up to 31% of 
the variance in pain ratings (Sullivan et al., 2001). Of even greater importance is the 
theory behind how catastrophizing is thought to augment the pain experience. Similar to 
the concept of an irrationally negative outlook on the future that is associated with the 
catastrophizing found in anxiety and depression, pain catastrophizing is the tendency to 
exaggerate the level of pain threat coupled with pain-related worry and fear (Chaves & 
Brown, 1987; Spanos, Radtke-Bodorik, Ferguson, & Jones, 1979). Pain catastrophizing, 
then, appears to augment the experience and reporting of daily pain in this FM sample.  
 Greater levels of baseline pain catastrophizing were also found to predict 
increased objective wake after sleep onset (WASO) and increased subjective time in 
bed (SRTIB). These findings suggest that individuals who catastrophize about their 
pain, in addition to reporting more daily pain, also objectively experience and 
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subjectively report poorer sleep. Although there is significantly less evidence in the 
literature of a link between pain catastrophizing and sleep, the studies that have 
evaluated this relationship have found an association between higher pain 
catastrophizing and poorer sleep with both experimental pain testing and chronic pain 
populations (Goodin et al., 2011; Lee et al., 2013).   
 Patients who reported greater baseline pain also reported feeling less refreshed 
upon awakening than individuals who reported lower levels of baseline pain. It is 
surprising that baseline pain significantly predicted less refreshing sleep while daily pain 
did not. One explanation for this may be the way that pain was assessed at baseline. 
Participants were asked to report their worst, least, and average pain over the past 
week, as well as their current level of pain at the time of assessment. The interpretation 
of this retrospective measure may have actually assessed how participants had been 
“feeling” in the past week, including their fatigue, sleepiness, etc, in addition to their 
pain. Daily pain assessments, on the other hand, were not retrospective and may have 
captured a different aspect of the participants’ pain. 
 Baseline depression was a predictor of objective time in bed (TIB) as well as 
most of the subjective sleep variables. Individuals who reported higher levels of 
baseline depression spent more time in bed—and this was confirmed with actigraphy—
and also reported that they took longer to fall asleep, spent more time awake during the 
night, had a lower sleep efficiency, and reported feeling less refreshed upon awakening 
than those who reported lower levels of depression. These findings are consistent with 
the literature on sleep and depression in FM (Miró et al., 2011; Munguia-Izquierdo & 
Legaz-Arrese, 2012). A recent study by Roehrs et al. (2013) found that individuals with 
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FM reported greater subjective sleepiness and fatigue than individuals with rheumatoid 
arthritis or healthy controls, but had the least objective daytime sleepiness as assessed 
by the Multiple Sleep Latency Test. It was concluded that this increased latency to sleep 
in FM is due to a state of hyperarousal, and this may be particularly true for individuals 
with more depression. In addition, one of the diagnostic criteria for Major Depressive 
Disorder is sleep disturbance (American Psychiatric Association, 2013). Similar to our 
findings, the classic insomnia-type sleep problems in depression are characterized by 
reports of difficulty falling asleep, waking intermittently throughout the night, and feeling 
unrefreshed upon awakening (Armitage, 2006). The fact that self-reported depression in 
our study is more predictive of self-reported poor sleep than of objectively-measured 
sleep quality suggests that individuals who are more likely to report high levels of 
depression are also more likely to report poor sleep regardless of the sleep they 
objectively obtain. This is similar to a study by Edinger et al. (2000) that found that 
psychological factors, including depression and anxiety, were related to subjectively-
reported insomnia, but were not related to objectively-recorded sleep.    
 One aspect of depression is the experience of negative emotion, or negative 
affectivity. Surprisingly, baseline negative affect was not predictive of any subjective or 
objective sleep variables, suggesting that this construct is at least somewhat distinct 
from depression. Whereas high baseline depression was predictive of poorer nightly 
sleep, the lack of relationship between negative affect and sleep provides further 
support that the construct of depression contains unique aspects beyond negative 
affect. Perhaps it is the low positive affect / low energy component of depression that is 
more related to sleep difficulties than the negative affect component of depression.  
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 The finding that baseline depression and negative affect did not significantly 
predict daily pain across individuals was surprising given previous literature that 
individuals with FM have higher levels of depression than those without a FM diagnosis 
and that pain intensity is positively associated with depression (Miró et al., 2011). 
Similarly, baseline depression and negative affect were not correlated with baseline 
pain, which again is surprising. One possible explanation is that both pain and 
depression were elevated in this population and the relationship between these factors 
was eliminated due to the narrowed range of scores.  
 Within-Person Sleep and Pain 
 As mentioned previously, average, between-person analyses do not speak to the 
direction of the sleep and pain relationship, necessitating within-person, daily analyses. 
Therefore, the nightly objective and subjective sleep variables were analyzed as 
predictors of next day’s pain. Despite the examination of several sleep variables over 
the 14-day assessment period, there were relatively few findings. Results showed that 
individuals who reported feeling relatively unrefreshed upon awakening experienced 
more self-reported pain the rest of the day. This finding is consistent with the 
established literature that has found poor self-reported sleep quality to be a predictor of 
increased pain (Ağargün et al., 1999; Bigatti et al., 2008; Tang et al., 2012; Theadom et 
al., 2007).  
 Daily pain was also analyzed as a predictor of the next night’s objective and 
subjective sleep variables. Only one sleep variable was predicted by daily pain. 
Individuals who reported more than their average pain one day experienced a greater 
self-reported latency to sleep (SOL) the following night. This suggests that pain does 
63 
 
 
not interfere with sleep once it has been initiated, but that it does prevent the onset of 
sleep. Increased latency may also represent the hyperarousal state that has been 
shown in FM and mentioned previously (Roehrs et al., 2013). 
 These within-person findings suggest that while there does appear to be a 
bidirectional relationship between sleep and pain, this only applies to a few sleep 
variables. The strongest relationship was found between daily self-reported refreshing 
quality of sleep and next day pain; a finding that is consistent with the literature (Finan 
et al., 2013). In the other direction, daily pain was predictive of self-reported sleep onset 
latency (SOL) the next night. One thing that is consistent when looking at the day-to-day 
relationship between sleep and pain is that this relationship is stronger with subjective 
sleep variables than with sleep variables measured with actigraphy. One possible 
explanation for this finding is that perception of sleep one night has more influence on 
self-reported next-day pain than objectively-measured sleep, and that perception of 
daily pain impacts reports of the next night’s sleep more than sleep measured with 
actigraphy. Other possible explanations, which will be addressed in the limitations 
section, are shared methods variance of self-report predicting self-report for the sleep 
and pain variables, as well as a lack of validity in the sleep variables assessed with 
actigraphy. 
Moderators of the Sleep and Pain Relationship 
 The second major aim of this dissertation was to determine what individual 
difference factors moderate the daily sleep / pain relationship. The baseline measures 
of depression, negative affect, age, and pain catastrophizing were analyzed to 
determine if each individually predicted the relationship between daily objective and 
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subjective sleep variables and next day’s pain as well as the relationship between one 
day’s pain and the next night’s objective and subjective sleep variables.  
 Age was found to significantly moderate the relationship between one night’s 
subjective sleep onset latency (SOL) and the next day’s pain, such that older individuals 
had a stronger, positive relationship between these variables compared with younger 
individuals, who had no relationship between subjective SOL and next day’s pain. As 
noted above, older individuals experienced significantly lower daily pain than younger 
individuals, but this difference was more pronounced for those individuals who reported 
shorter subjective SOL the previous night compared with those who reported longer 
SOL. Interestingly, age was also a significant moderator of the relationship between 
daily pain and the next night’s subjective SOL, such that there was a stronger, positive 
relationship between one day’s pain and the next night’s subjective SOL for individuals 
who were older compared with no relationship for those who were younger. Older 
individuals had greater self-reported SOL than younger people, and this finding was 
more pronounced for individuals who reported higher levels of pain the previous day 
compared with those who reported lower levels of pain.  
 Thus, in older individuals, daily subjective SOL and daily pain are positively 
correlated in both directions, and possibly influence each other. In contrast, younger 
individuals do not appear to have any relationship between subjective SOL and pain, 
but they have higher levels of pain and shorter subjective SOL than individuals who are 
older. Perhaps younger individuals have unique characteristics that explain these 
findings, such as obtaining less sleep due to work or family obligations. Although not 
statistically significant, younger individuals tended to have less time in bed, less total 
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sleep time, and more wake after sleep onset than older individuals, suggesting that the 
younger participants may have been sleepier, and therefore, experienced more pain. 
Another explanation is that as individuals age, there may be adaptation to both affect 
and FM, resulting in the condition being less driven by affective dysregulation. Older 
people may become more regulated with age, or the FM pain processes may become 
less dependent on state factors such as mood and sleep. 
 Baseline depression was also examined as a potential moderator. Depression 
significantly moderated the relationship between refreshing sleep and next day’s pain, 
such that more refreshing sleep predicted less pain subsequently, among those 
participants who were more depressed at baseline, compared with no relationship for 
those who were less depressed. This finding suggests that the perception of sleep 
quality has more impact on next day’s pain for those individuals who reported high 
levels of baseline depression than those who reported lower levels of depression. 
Depression also significantly moderated the relationship between daily pain and refresh 
score upon awakening the next morning, such that there was a stronger, negative 
relationship between daily pain and the next night’s refreshing quality of sleep for 
individuals who reported higher levels of baseline depression compared with the non-
significant relationship between daily pain and next night’s refreshing quality of sleep for 
individuals who reported lower levels of baseline depression. This finding suggests that 
there is less impact of baseline depression on refreshing quality of sleep when an 
individual experiences less pain the previous day.  
 Thus, in combination, these two moderator findings indicate that individuals who 
report higher levels of baseline depression have a negative relationship between pain 
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and refreshing quality of sleep in both directions, with these variables likely reciprocally 
influencing one another. That is, among the relatively depressed patients, refreshing 
sleep one night leads to less pain the next day, which leads to more refreshing sleep 
the following night. In contrast, those who reported lower levels of baseline depression 
did not exhibit the expected negative relationship between pain and refreshing quality of 
sleep. These findings suggest that the link between pain and sleep exists among those 
with depression because higher levels of depression are associated with increased 
reports of pain (Miró et al., 2011) as well as feeling unrefreshed upon awakening 
(Armitage, 2006). In addition, the relationship between sleep and pain is strengthened 
by the presence of depression. The negative sleep and pain relationship for individuals 
high in depression may be due to the presence of “subtypes” of FM. One subtype may 
be affectively dysregulated, in which a number of systems become disturbed including 
sleep, pain, and affect, allowing them to covary more tightly. A contrasting subtype of 
FM may have less affect dysregulation and system disruption, so the sleep, pain, and 
affect variables do not covary. This is consistent with the subtype model of FM offered 
by Turk, Okifuji, Sinclair, and Starz (1996), who proposed that there are “dysregulated,” 
“interpersonally distressed,” and “adaptive coper” types of FM patients. 
 Very similar results were also found with baseline negative affect, such that  
there was a stronger, negative relationship between self-reported refreshing quality of 
sleep and next day’s pain for individuals who reported higher levels of baseline negative 
affect, compared with no relationship for those reporting lower levels of baseline 
negative affect. This finding suggests that the construct of negative affect moderates the 
relationship of one night’s refreshing quality of sleep on next day’s pain in the same way 
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that was found with depression. This may be due to the negative expression of emotion 
contained in both depression and negative affect, or may speak to the relationship 
between one night’s refreshing quality of sleep on next day’s pain. Individuals who 
report low refreshing quality of sleep may also express negative affectivity in general, 
suggesting why both high negative affect and high depression would respond similarly. 
 Negative affect significantly moderated the relationship between objective total 
sleep time (TST) and next day’s pain, such that there was a small, negative relationship 
between objective TST and next day’s pain for individuals who reported higher levels of 
baseline negative affect, compared with a small, positive relationship between objective 
TST and next day’s pain for those who reported lower levels of baseline negative affect. 
Interestingly, as total sleep time increased, the effect of negative affect on daily self-
reported pain attenuated, suggesting that negative affect has a greater impact on daily 
pain when an individual has less sleep the previous night.  
 Pain catastrophizing significantly moderated the relationship between objective 
sleep efficiency (SE) and next day’s pain, such that there was a small, negative 
relationship between objective SE and next day’s pain for individuals who reported 
higher levels of baseline pain catastrophizing and a small, positive relationship between 
objective SE and next day’s pain for those who reported lower levels of baseline pain 
catastrophizing. This finding suggests that as sleep efficiency increases, baseline pain 
catastrophizing has less of an impact on next day’s pain. Pain catastrophizing was also 
found to significantly moderate the relationship between daily pain and the next night’s 
objective SE, such that there was a negative relationship between daily pain and 
objective SE for individuals who reported higher levels of baseline pain catastrophizing 
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compared with the almost equally positive relationship between daily pain and objective 
SE for individuals who reported lower levels of baseline catastrophizing. This finding 
suggests that the interpretation of the experience of pain has a significant impact on the 
way that one day’s pain is related to the next night’s sleep efficiency. 
 Thus, individuals who report higher levels of baseline pain catastrophizing have a 
negative relationship between pain and objective sleep efficiency in both directions, with 
these variables potentially influencing one another. In contrast, those who reported 
lower levels of baseline pain catastrophizing did not exhibit the expected negative 
relationship between pain and refreshing quality of sleep. More importantly, the findings 
seem to be consistent with the other predictors of baseline depression and age; 
individuals who report higher baseline catastrophizing and depression, as well as those 
who are older, show the expected “poor sleep and higher pain” relationship. The similar 
relationships among these moderator variables suggest a consistent effect. This is not 
surprising for baseline pain catastrophizing and baseline depression since these 
variables were positively correlated with each other and there are consistent findings in 
the literature that individuals who catastrophize about their pain and report symptoms of 
depression have poor sleep and increased pain compared with those who are lower in 
catastrophizing and depression (Goodin et al., 2011, Miró et al., 2011, Sullivan et al., 
2001). On the other hand, it is surprising that older individuals demonstrated the 
expected “poor sleep and higher pain” relationship, especially since they reported lower 
levels of depression and pain catastrophizing. One possible explanation for this finding 
may be that older individuals had more variability in their daily pain and sleep onset 
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latency (SOL) than younger individuals, allowing for a relationship between sleep and 
pain.   
Limitations of the Study 
 Although this study has many strengths, such as the use of a relatively large and 
homogeneous chronic pain population of individuals with FM, and the utilization of both 
objective and subjective measures of sleep, there are several limitations that I will now 
address. One limitation is that all of the participants were individuals who sought 
participation in a treatment study for stress. Thus, this self-selected sample may have 
unique characteristics, such as having high rates of affect disorders, trauma histories, 
etc. that are not representative of the larger FM population. Results should therefore be 
interpreted with caution. Additionally, the study sample consisted of only individuals with 
a diagnosis of FM; therefore, the findings may not be generalizable to other chronic pain 
populations, particularly conditions with younger individuals, with more men, and that 
have pain with less affective dysregulation. 
 Another limitation is the use of paper diaries for collecting daily subjective sleep 
and pain variables. Although the participants were taught how to complete the diaries 
and when to answer the various questions about their sleep and pain, there was no 
independent validation of when the diary was completed. Similarly, the use of a once-
daily pain rating collected on paper is a limitation of the study. Assessing pain at 
multiple points throughout the day and utilizing electronic diaries for sleep and pain 
variables would ensure timely completion of these temporal variables and allow for 
analyses of daily pain fluctuation. All of the diary data were also based on self-report 
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measures of sleep and pain. Therefore, the relationships found among the variables 
may be accounted for, at least in part, by shared method variance.  
 The study is also correlational in nature, rather than experimental. Therefore, no 
definitive causal interpretations can be made about the sleep and pain relationship. 
Although the data suggest a potential bidirectional relationship, there were no good 
estimates for determining which direction of the effect is stronger. Another limitation of 
the study is that the lag was only one day, assessing one night’s sleep on next day’s 
pain and one day’s pain on the next night’s sleep. It is possible that effects took longer 
to manifest and longer lag periods should have been tested in the analyses. 
Additionally, increasing the study period beyond 14 days may have also resulted in 
more reliable estimates.  
 The utilization of actigraphy, although a strength for collecting objective sleep 
data, may also be a limitation of this study. Actiwatches are an excellent method for 
assessing participant movement, but there is some question about the validity of sleep 
variables collected with actigraphy. Although assessment studies have shown a high 
level of agreement for sleep scored from polysomnography and actigraph algorithms (r 
= 0.85), this is only for normal individuals (Acebo, 2006). Accuracy of sleep and wake 
measured with actigraphy tends to decrease when sleep is disturbed, as is often the 
case in chronic pain populations (Kushida et al., 2001). There is also little evidence for 
the validity of several sleep variables collected with actigraphy, including sleep onset 
latency and wake after sleep onset (Acebo, 2006).  In addition, actigraphy was scored 
with the aid of self-reported diary variables that include limitations stated above. For 
example, many participants had periods of “inactivity” as measured with actigraphy that 
71 
 
 
did not correspond to the times that were recorded in the diary for sleep. Therefore, it 
was unclear if the participants were asleep, sitting very still, or had removed the 
actiwatch during these periods. Ambiguous periods of time were eliminated from 
analyses, which may have underestimated the total sleep time for some participants. 
 Another limitation of the study is that it would have been ideal to assess more 
measures during the daily recording period. Negative affect, depressive symptoms, and 
pain catastrophizing were assessed as trait-type measures, asking participants to 
respond based on how they typically feel over longer periods of time. These measures 
could also have been assessed from day to day, allowing me to test how they 
influenced the sleep / pain relationship. Another measure that would have been ideal to 
assess daily is pain interference. The long version of the Brief Pain Inventory (BPI; 
Cleeland & Ryan, 1994) consists of a pain interference component in addition the pain 
intensity component assessed at baseline in this study. Daily pain interference may be a 
more important outcome measure than pain intensity for determining the impact of poor 
sleep the previous night.  
 The final limitation is the analysis of so many objective and subjective sleep 
variables in the analyses. Sleep efficiency was predicted to be the sleep variable of 
interest for this study, but it was not significantly related to daily pain in unmoderated 
relationships. Other sleep variables were then analyzed to determine their relationship 
with daily pain, and very few of the analyzed variables resulted in significant findings. 
Therefore, there is concern regarding Type 1 error for these sleep variables, and the 
results should be interpreted with caution. 
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Implications and Future Directions 
 This study suggests that there is a bidirectional relationship between sleep and 
pain, with daily refreshing quality of sleep predicting next day’s pain, and one day’s pain 
predicting the next night’s subjective sleep onset latency. Average objective wake after 
sleep onset also predicted daily pain, and daily pain predicted average objective wake 
after sleep onset. In addition to the daily sleep and pain findings, several factors that 
explained individual differences in the sleep and pain relationship including depression, 
negative affect, age, and pain catastrophizing were assessed as moderators. Age, 
depression, and pain catastrophizing all exhibited bidirectional moderation of the sleep 
and pain relationship; age moderated the self-report sleep onset latency and pain 
relationship, depression moderated the refreshing quality of sleep and pain relationship, 
and pain catastrophizing moderated the objective sleep efficiency and pain relationship. 
In addition, individuals who were older as well as those who reported higher levels of 
baseline depression and pain catastrophizing demonstrated the expected results of 
poorer sleep being associated with increased pain. The similar relationships among 
these moderator variables suggest a consistent effect. These findings provide more 
support for the temporal relationship of daily sleep and pain and indicate that there are 
individual factors that should be considered in evaluating this relationship. 
 There are many questions that remain unanswered, however. Although there 
was a relationship between sleep and pain for a few select sleep variables, it is unclear 
as to why other objective and subjective sleep variables were not associated with daily 
pain. It is also unclear why depression and negative affect were not related to baseline 
pain or daily pain. This finding is not consistent with the literature, and future studies 
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should evaluate the relationship of depression and negative affect with pain to 
determine if this finding can be replicated. Future studies should also explore increasing 
the length of sleep and pain data collection as well as other methodologies for collecting 
diary data that increase the reliability of temporal self-report measures. 
 In conclusion, this dissertation adds to the established literature on the 
relationship between sleep and pain, utilizing objective and subjective measures of 
sleep within a large chronic pain population of individuals with FM. Future research 
should focus on individual differences in the sleep and pain relationship in order to 
determine if there are more significant moderation relationships among these variables.  
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APPENDIX A: ACTIWATCH LOG 
 
 
INSTRUCTIONS 
Thank you for agreeing to take part in our study and wearing the Actiwatch.  
This watch-like device records your daily movement and will help us better 
understand sleep-wake cycles, activity levels, and daily pain ratings. The 
information you provide in this workbook will help the researchers analyze the 
data captured on your Actiwatch.  
Fill out the questions in this book each day you are asked to wear the Actiwatch.  
Morning questions are about the previous night’s sleep. 
At the end of each day, we ask you to record your average pain rating for the day 
in this logbook.  
 
Some reminders: 
• Wear the watch on your non-dominant wrist. 
• There is no need to turn the watch on, it will begin recording by itself. The 
watch does not appear to be doing anything, but it is recording your 
movement. 
• Please note in your logbook anytime during the day you take the watch off 
(to shower, etc). 
• Bring your watch and logbook with you to your next study visit. 
 
Please contact the study coordinator if you have any questions or concerns about 
wearing this device. 
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Day 1 
Mon / Tue / Wed / Thu / Fri / Sat / Sun 
 
 
 
 
Today's Date:   __ __ / __ __ / __ __ __ __ 
 
Morning Questions 
1. What time did you turn off the light and try to go to sleep last night?   
: AM / PM 
2. How many minutes did it take you to fall asleep last night? 
    minutes 
3. How many times did you wake up last night before you woke up to start your day? 
    times 
4. How many total minutes were you awake last night from these awakenings? 
    minutes 
5. What time did you wake up this morning to start your day?   
: AM / PM 
6. Using the scale below, please rate how refreshed you feel after last night’s sleep. 
0 1 2 3 4 5 6 7 8 9    10 
Not at all 
refreshed 
         Completely 
refreshed 
 
Evening Questions 
7. Did you take off the watch today (to shower, swim, etc.)?  If so, please record: 
Time that I took off the watch Approx length of time watch was off  
: AM / PM  minutes 
: AM / PM  minutes 
: AM / PM  minutes 
: AM / PM  minutes 
 
8. Using the scale below, please rate your average pain today. 
 
 
 
0 1 2 3 4 5 6 7 8 9 10 
No 
Pain 
         Pain as bad as 
you can imagine 
 
- End of questions for today– 
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APPENDIX B: BASELINE MEASURES 
 
CES-D 
 
Below is a list of ways you might have felt or behaved.  Please indicate how often you have felt 
this way during the PAST WEEK by placing a check in the box below your response. 
 
 
 
 
 
 
In the past week: 
Rarely or 
none of the 
time  
(less than 1 
day) 
Some or a 
little of the 
time  
(1 to 2 days) 
Occasionally 
or a 
moderate 
amount of 
the time 
(3 to 4 days) 
Most or all 
of the time  
(5 to 7 days) 
 
1. I was bothered by things that 
usually don't bother me.     
2. I did not feel like eating; my 
appetite was poor.     
3. I felt that I could not shake off the 
blues even with help from my 
family or friends. 
    
4. I felt that I was just as good as 
other people.     
5. I had trouble keeping my mind on 
what I was doing.     
6. I felt depressed.     
7. I felt that everything that I did as 
an effort.     
8. I felt hopeful about the future.     
9. I thought that my life had been a 
failure.     
10. I felt fearful.     
11. My sleep was restless.     
12. I was happy.     
13. I talked less than usual.     
14.  I felt lonely     
15. People were unfriendly.     
16. I enjoyed life.     
17. I had crying spells.     
18. I felt sad.     
19. I felt that people dislike me.     
20. I could not get going     
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PCS 
 
  
Everyone experiences painful situations at some point in their lives. Such experiences may 
include headaches, tooth pain, joint or muscle pain. People are often exposed to situations that 
may cause pain such as illness, injury, dental procedures or surgery.  
Instructions:  
We are interested in the types of thoughts and feelings that you have when you are in pain. 
Listed below are thirteen statements describing different thoughts and feelings that may be 
associated with pain. Using the following scale, please indicate the degree to which you have 
these thoughts and feelings when you are experiencing pain. 
 
 RATING  0  1  2  3  4  
MEANING  Not at all  To a slight 
degree  
To a 
moderate 
degree  
To a great 
degree  
All the time  
 
 When I’m in pain … 
 
 Number  Statement  Rating 
1  I worry all the time about whether the pain will end.   
2  I feel I can’t go on.   
3  It’s terrible and I think it’s never going to get any better   
4  It’s awful and I feel that it overwhelms me.   
5  I feel I can’t stand it anymore   
6  I become afraid that the pain will get worse.   
7  I keep thinking of other painful events   
8  I anxiously want the pain to go away   
9  I can’t seem to keep it out of my mind   
10  I keep thinking about how much it hurts.   
11  I keep thinking about how badly I want the pain to stop   
12  There’s nothing I can do to reduce the intensity of the pain   
13  I wonder whether something serious may happen.   
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BPI 
 
1. Please rate your pain by circling the one number that best describes your pain at its worst in the 
last week. 
  
 0  1 2 3 4 5 6 7 8 9 10 
    No pain         Pain as bad as  
           you can imagine 
 
 
2. Please rate your pain by circling the one number that best describes your pain at its least in the 
last week. 
  
 0  1 2 3 4 5 6 7 8 9 10 
    No pain         Pain as bad as 
                    you can imagine 
 
 
3. Please rate your pain by circling the one number that best describes your pain on the average for 
the last week. 
  
 0  1 2 3 4 5 6 7 8 9 10 
    No pain         Pain as bad as 
                    you can imagine 
 
 
4. Please rate your pain by circling the one number that tell how much pain you have right now. 
 
0  1 2 3 4 5 6 7 8 9 10 
    No pain         Pain as bad as 
                  you can imagine 
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PSQI 
 
Instructions: The following questions relate to your usual sleep habits during the past month 
only. Your answers should indicate the most accurate reply for the majority of days and nights in 
the past month. Please answer all questions. 
 
During the past month, 
1. What TIME have you usually gone to bed? ________________________ 
2. How long (in minutes) has it taken you to fall asleep each night? _______________________  
3. What TIME have you usually gotten up in the morning? _______________________ 
4. How many hours of actual sleep do you get at night? (This may be different than the number of hours 
you spend in bed) _______________________ 
 
5. During the past month, how often have you had 
trouble sleeping because you… 
Not during 
the past 
month 
 (0) 
Less that 
once a 
week  
(1) 
Once or 
twice a 
week  
(2) 
Three or 
more 
times a 
week 
 (3) 
a. Cannot get to sleep within 30 minutes     
b.  Wake up in the middle of the night or early 
morning 
    
c. Have to get up to use the bathroom     
d.  Cannot breathe comfortably     
e.  Cough or snore loudly     
f.  Feel too cold     
g.  Feel too hot     
h.  Have bad dreams     
i.  Have pain     
 
j. 
 Other reason(s), please describe, including how 
often you have trouble sleeping because of this 
reason(s): 
    
6. During the past month, how often do you take 
medicine (prescribed or “over the counter”) to 
help you sleep? 
    
7. During the past month, how often have you had 
trouble staying awake while driving, eating 
meals, or engaging in social activity? 
    
8. During the past month, how much of a problem 
has it been for you to keep up enthusiasm to get 
things done? 
    
  Very Good 
 (0) 
Fairly 
Good  
(1) 
Fairly 
Bad  
(2) 
Very Bad  
(3) 
9. During the past month, how would you rate 
your sleep quality overall? 
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PANAS 
 
This scale consists of a number of words and phrases that describe different feelings and 
emotions. Read each item and then circle the number that corresponds to the appropriate 
answer. Indicate to what extent you have felt this way during the past few weeks. Use the 
following scale to record your answers: 
 
 
Very 
slightly or 
not at all 
A little Moderately Quite a bit Extremely 
1. interested      
2. irritable      
3. distressed      
4. alert      
5. excited      
6. ashamed      
7. upset      
8. inspired      
9. strong      
10. nervous      
11. guilty      
12. determined      
13. scared      
14. attentive      
15. hostile      
16. jittery      
17. enthusiastic      
18. active      
19. proud      
20. afraid      
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Fibromyalgia (FM) impacts millions of individuals around the world and is 
characterized by widespread chronic pain and tenderness as well as nonrestorative 
sleep, fatigue, and stiffness (Wolfe et al., 1990; Wolfe et al., 2010). Poor sleep quality is 
reported by more than 90% of individuals with FM, suggesting that sleep disturbance 
may be a contributing factor to the pain experience (Moldofsky, 2008). Recent reviews 
of the literature have established the connection between sleep and pain, although the 
direction of this relationship remains unclear (Finan et al., 2013; Moldofsky, 2001). This 
dissertation sought to examine the daily relationship between sleep and pain in a large 
population of chronic pain patients with fibromyalgia (FM), as well as the factors that 
may explain individual differences in this relationship. Ninety adults with FM completed 
baseline self-report measures of depression, negative affect, pain, sleep disturbance, 
and pain catastrophizing. Participants also wore an actiwatch, an objective 
measurement of sleep, for two weeks while completing daily diaries about their sleep 
and pain.  Hierarchical linear modeling (HLM) was utilized to examine the intraindividual 
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variability in daily sleep and pain among participants, as well as the baseline factors that 
explain individual differences in this relationship.  
 Results of this study suggest that there is a bidirectional relationship between 
sleep and pain, with daily refreshing quality of sleep predicting next day’s pain, and one 
day’s pain predicting the next night’s self-reported sleep onset latency. Average 
objective wake after sleep onset also predicted daily pain, and daily pain predicted 
average objective wake after sleep onset. In addition to the daily sleep and pain 
findings, several factors that explained individual differences in the sleep and pain 
relationship including depression, negative affect, age, and pain catastrophizing were 
assessed as moderators. Age, depression, and pain catastrophizing all exhibited 
bidirectional moderation of the sleep and pain relationship, and individuals who were 
older as well as those who reported higher levels of baseline depression and pain 
catastrophizing demonstrated the expected results of poorer sleep being associated 
with increased pain. The similar relationships among these moderator variables suggest 
a consistent effect. These findings provide more support for the temporal relationship of 
daily sleep and pain and indicate that there are individual factors that should be 
considered in evaluating this relationship.  
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